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ABSTRACT
Functional brain imaging technologies seek to expand our understanding of intact neural systems.
Present day functional MRI (fMRI) measures the delayed hemodynamic response that is indirectly
associated with neural activity. To study underlying molecular systems noninvasively but precisely, tools
must be developed to modulate MRI contrast as a function of discrete molecular events within
pathways of interest. In optical imaging modalities, genetically encoded sensors based on fluorescent
proteins have provided an engineerable platform on which to optimize desirable device characteristics
by exploiting the tools of molecular biology and protein biochemistry. Analogously, we seek to build
genetically encodable sensors based on engineered metalloproteins whose effects on MRI contrast are
regulated by specific biochemical interactions.
In this work, we present two technological advancements toward realizing fMRI contrast sensors for
molecular neuroimaging. First, a genetically encodable sensor for free calcium is described, consisting of
a novel ferritin-based device that reversibly enhances NMR transverse relaxation times (T2) by Ca -
dependent crosslinking. Second, we show that the T1 contrast effect of a recently proposed family of
cytochrome P450-based MRI sensors can be significantly enhanced by substitution of the protein's
native heme with a high spin manganese porphyrin.
Thesis Supervisor: Alan P. Jasanoff
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1 Introduction
1.1 Overview
Functional imaging is a critical tool for unraveling the complex systems of the brain. Work to
associate stimuli with brain activity has flourished particularly with the discovery of a blood oxygen level
dependent (BOLD) effect on MRI signal only two decades ago [1]. Despite these rich returns, notable
concerns remain as to the linearity, uniformity, and interrogative scope of the linkage between neural
activation and changes in blood flow [2]. Since the BOLD response only reflexively indicates vascular
compensation for brain activity [3], it is apparent that the precise molecular and cellular events in neural
processing-and thus the critical questions in neuroscience-cannot be interrogated via the BOLD
response alone. Alternatively, the ideal manifestation of a neuroactivity measurement device would be
one that noninvasively senses electrochemical dynamics with high spatial and temporal resolution [4].
Toward analogous goals, molecular biology and protein biochemistry have produced instructive
successes in molecular sensing, especially for application in optical imaging modalities [5,6],
demonstrating that protein is a uniquely suited substrate on which to design molecular-level devices in
biological contexts. In this thesis, we present two technological advances that approach the goal of
creating engineered protein devices that can be detected noninvasively and that sense molecules
functioning directly in the neurobiology of brain activity.
1.2 Toward a systems-level understanding of neuroscience
In its recent history, neuroscience has sought to integrate fascinating lessons derived from
behavioral neuroscience with the mechanistic detail unearthed by neurobiologists at the molecular and
cellular levels. Now, with the application and advancement of new technologies [7,8,9], the field is
nearing a critical convergence of its various subdisciplines. The crossroads is likely to be found in the
advancement of engineering approaches that seek to computationally integrate the vast connectivity
and regulatory information of complex biological systems. Rather than serially studying relationships
between behaviors and a small set of molecules, cells or brain structures, new technologies enable
researchers to probe the complex pattern of connectivities and molecular processes underlying neural
function. Concurrent with the rise of informatics analyses in systems biology, neuroscience will benefit
from approaches that probe holistic networks of molecular and cellular processes, ultimately generating
systematic models with predictive power [10].
Efforts in this direction are already underway. Genetic methods to probe and analyze neural
circuitry have yielded fascinating insights into the complex organization of neuronal circuitry [11],
including a complete mapping of synaptic contacts arising from single neurons [12]. To take full
advantage of such tools requires correlating electrophysiological data of direct neuronal activation with
advanced imaging modalities capable of answering spatiotemporal questions noninvasively in vivo
[13,14]. So far, these technologies include positron emission tomography (PET) [7], optical tomography
[15], and functional magnetic resonance imaging (fMRI). The last of these techniques has a unique
advantage for neuroimaging because adequate spatial (<100 pim) and temporal (<1 s) resolution is
routinely achievable over the field of view of the whole brain [2]. However, the interrogative scope of
current fMRI methods is, as we shall see, limited by the nature of the contrast mechanism currently in
widespread use [8].
1.3 fMRI and BOLD fMRI
Envisioned as an analytical technique, fMRI is a method for observing functional processes by
measuring the nuclear magnetic resonance (NMR) signal resolved in space and time. As it is primarily
conceived of today, fMRI relies upon the endogenous oxygen sensor hemoglobin. Linus Pauling was the
first to observe that oxygen-bound hemoglobin is diamagnetic, whereas unbound deoxyhemoglobin is
paramagnetic [16]. Since hemoglobin concentration is at millimolar concentrations (around 150 g/L) in
whole blood [17], small changes in the concentration of oxyhemoglobin within a blood-supplied tissue
result in measurable changes in NMR signal intensity in T2-weighted imaging sequences [1].
This observation is the basis of the blood oxygen level dependent (BOLD) response (Figure 1). It
has been proposed that a tight coupling exists between energy-dependent processes in neurons, cellular
respiration, and blood supply [3]. The model suggests that neural activity and associated respiration
results in an increased local demand for oxygen from nearby vasculature. Initially, a short local transient
in deoxyhemoglobin is followed by subsequent vasodilation that compensates for oxygen demand with
augmented blood flow and volume, locally increasing the diamagnetic oxyhemoglobin content of nearby
tissue. This results in a measurable decrease in local T2 relaxation rates and therefore an increase in
NMR signal intensity in T2-weighted images (Figure la). These compensatory vascular effects are
collectively termed "hemodynamic" responses [8,18].
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Figure 1. BOLD fMRI measures the delayed hemodynamic response after neural activity. (a) Changes
in blood oxygenation fraction and vascular diameter modulate T2-weight signal intensity, as initially
observed by Ogawa et al. (Adapted from [1]). (b, c) Logothetis et al. present a validation of the
relationship between microelectrode-recorded local field potentials and the delayed BOLD response in
monkey visual cortex during rotating checkerboard-pattern stimulation. In (c), raw (black) and root-
mean-square (yellow) electrical signals are plotted alongside BOLD response (red) in the indicated
region of interest in (b). Adapted from [19].
However, questions remain about the detailed mechanistic linkage between hemodynamics and
neural activity in functional contexts [2,4]. While the relationship between the BOLD signal and
electrical measurements evoked by short stimuli has been directly observed in the monkey visual cortex
to be, in essence, a linear filtering of local field potentials [19] (Figure 1b,c), the linearity and
spatiotemporal homogeneity of the relationship has been less apparent elsewhere [20,21,22].
Interpretation of fMRI "activation maps" is complicated by the coarse connection between
hemodynamics and underlying processes occurring within microcircuits of any apparently activated
voxel. Specifically, both excitatory and inhibitory effects can result in increased metabolic demand, as
well as concurrent increases excitation and inhibition [8]. Conservatively, even when independently
validated within a specific experimental context, BOLD fMRI can at best phenomenologically indicate
regional processes acting in a manner correlating with a behavior or stimulus within the region and
conditions specifically validated [21]. Accordingly, it may never be able to deconstruct satisfactorily-
without the aid of other more invasive and disruptive techniques-the underlying mechanism of
neurological processes that span into unvalidated spatial regions and experimental conditions.
The Achilles' heel of present day the fMRI technique, therefore, lies not in the technological
capabilities of the imaging modality, but rather in the limited interrogative power of the physiological
contrast mechanism underlying the BOLD effect. We believe that newly engineered contrast agents for
molecular fMRI can overcome this limitation. Specifically, our group has recently advanced the notion
that direct molecular measurements can be taken with the aid of molecular sensors whose contrast
enhancement is modulated as a function of specific chemical events [14].
1.4 Engineering contrast sensors for molecular fMRI imaging
1.4.1 Proton NMR relaxation processes
Classical "static" MRI contrast agents are paramagnetic substances that modulate the relaxation
times of excited nuclear spins. Since there are two dominant relaxation processes, dubbed longitudinal
(T1) and transverse (T2) relative to the direction of an applied static magnetic field, methods have been
developed to both weight images and enhance contrast in manners dominantly associated with one
relaxation process or the other [23].
When a population of proton spins is placed in a static magnetic field, B0, the net magnetic
moment of the population slowly aligns with the direction of the field at a rate R1 = 1/T1 . While the net
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moment aligns directly along the field lines of BO, individual spin moments are precessing' about the
field lines at a characteristic frequency that is called the Larmour frequency, w,. Since there is a Zeeman
energy2 difference between spins dominantly precessing aligned with Bo and those aligned against BO, a
Boltzmann distributed subset of spins is precessing dominantly in the lower energy configuration,
parallel to the field? An RF pulse applied at precisely this resonance frequency can flip the population of
spins into the higher energy configuration, turning the net magnetization vector of the population some
angle away from BO, depending on the power and length of the applied pulse. Initially, this net moment
coherently precesses around BO with a component of its magnetization in an orthogonal or "transverse"
plane. A coherent signal from this effect can be detected as a sinusoid by a nearby receiver coil. As the
system then equilibrates to a low energy state, two relaxation processes take place. First, local spin-spin
interactions and field inhomogeneities cause a loss of coherence in the transverse component of the
magnetization, a process known as "dephasing" that occurs at a rate R2 = 1/T 2. Second, the net moment
of the magnetization slowly realigns with BO by exchanging energy with the surrounding "lattice" and
recovers its longitudinal magnetization vector in the direction of Bo at a rate R1.
Since T1 relaxation results in magnetization recovery in the longitudinal direction, brighter voxels
in T1-weighted images are those with faster T1 relaxation times, such that more signal can be flipped into
the transverse plane every at every repetition time-step, TR. Since T2 relaxation is a decaying process,
shorter T2 relaxation times cause a loss in signal for at an observed echo time, TE, and therefore voxels
with faster T2 relaxation rates appear darker than those with slower rates.
The classical macroscopic analogy for precession of the azimuthal spin angular momentum vector is the
observation that a spinning top or gyroscope spins on its azimuthal axis while its axis, in turn, rotates about the
axis of Earth's gravitational field lines.
2 Zeeman energy refers to an energy difference between eigenstates of the quantized spin angular
momentum that is amplified linearly by an applied magnetic field of increasing strength. At zero applied field,
these states are degenerate.
3 In fact, this is a loosely defined explanation from a quantum mechanical perspective, since all spins are
strictly in a linear combination of both the parallel and antiparallel eigenstates. In general, we choose to invoke a
classical explanation of the observable physics that is essentially a microscopic analogy inferred from the behavior
of a macroscopic population of spins.
Contrast agents generally accelerate NMR relaxation rates. Accordingly, T1 contrast agents
brighten signal on T-weighted images, whereas T2 contrast agents darken signal on T2-weighted images.
The extent of this effect is observed by measuring relaxation rate, R1 or R2, in some medium as a
function of contrast agent concentration. This slope of these relationships is a molar relaxation rate
constant, or relaxivity, r2 or r2. As theory has developed to describe the effects of contrast agents on
NMR relaxation, so too have molecular sensors whose relaxivity is modulated by specific chemical
events [4]. To understand mechanisms by which we may engineer contrast sensors that have specific
chemical sensitivity, it is instructive to explore, at least superficially, the theory that has been developed
to describe contrast agent effects on NMR relaxation.
1.4.2 Models of T, and T2 relaxivity enhancement by MRI contrast agents
In NMR, unpaired nuclear spins (e.g. protons) are excited by a pulse of energy matching their
precession frequency in an applied magnetic field. The relaxation of excited nuclear spins to
equilibrium, like all relaxation processes, relies on energy transfer to the surroundings. These relaxation
processes are enhanced by interactions between the excited nuclear spin angular momentum and that
of unpaired electron spins. The foundations for modern NMR relaxation theory in such paramagnetic
systems are the electron spin-nuclear spin relaxation equations presented by Solomon, Bloembergen
and Morgan (SBM) [24,25,26]. There is a rich history to advancements in paramagnetic relaxation
enhancement theory which is well beyond the scope of this introduction, but an instructive 1987 review
by Lauffer is an excellent resource for theory that pertains to paramagnetic ions with generally small
moments [27]. Recent efforts led by Gossuin, Roch, Muller, and Gillis [28,29] based on Freed [30,31]
have extended SBM theory to the rapid proton relaxation processes in fluids containing larger-moment
superparamagnetic and ferromagnetic species.
The dominant proton relaxation effects of magnetic species in solution are modeled by
partitioning the problem into so-called "reaction spheres." The molar relaxation time constants, r2
longitudinally or r2 transversely, are the superposition of relaxivity subprocesses associated with each
relevant reaction sphere. For many weakly paramagnetic radicals and ions, inner sphere effects on
directly coordinated waters dominate relaxivity for paramagnetic centers with small moments. In the
inner sphere, proton spins that can coordinate transiently with the paramagnetic center are rapidly
relieved of the energy in their excited spin state by the sum of scalar coupling (indirect nuclear
interaction via intervening electron spins) and stochastic dipole-dipole interactions mediated by
electron spins. The relaxation rate of the recipient electron spins, the rotational reorientation of the
paramagnetic complex, and the exchange rate of spins at coordination sites into the bulk then become
the dominant factors facilitating nuclear relaxation for spin populations. In their most basic form, these
inner sphere interactions are encompassed in the Solomon, Bloembergen, and Morgan (SBM) equations
describing the longitudinal relaxation time constant, 1/TiM for a water proton bound to a paramagnet
with spin S = Y2,
1 (2 ya 2R 2 [1 7Tc 3+ c 2 2 22 1)I= S(S+1) -yj'7- + (OT+- 1(), e
15 r6 1+ 22 1+ )221 3 h)1+ 22
which agrees reasonably well with experiment for low-spin paramagnetic species [27]. In this
expression, S is the spin quantum number, h is the reduced Planck's constant, and g is the electronic g-
factor, a dimensionless constant that relates the spin and magnetic moment of the electron. w, and ws
are the NMR precession frequencies associated with the nuclear spin, 1, and the electron spin, S,
respectively. A is a constant describing the strength of scalar spin-spin coupling. The gyromagnetic
ratios y, and ys linearly relate ws to the static field strength Bo and therefore govern the frequency
necessary to excite spins for any given instrument. The distance, r, is the separation between the
paramagnet and coordinated nuclear dipoles (i.e. the protons of bound water). As illustrated in slightly
more detail by Lauffer and Kowalewski et al., the correlation times re and re account for several complex
relaxation processes depending on the static field strength, the timescale of collisional distortions of the
coordination complex, the zero-field electron spin relaxation times, Tie, the chemical exchange lifetime
of spins in the inner sphere coordination sites, r, and the rotational correlation time, rR. (For
paramagnetic species with S >> /2, the scalar coupling and dipole-dipole components have been
modified to account for larger-moment effects. These updated modifications are explained in detail by
Kowalewski and colleagues [32].) For small paramagnetic ions, then, the inner sphere longitudinal
relaxivity is
rils - - q (2),
1,Is T1M im+ T
where Pm is the mole fraction of paramagnetic species in solution and q is the number of water
coordination sites at the paramagnetic species.
It should be noted that, beyond protons in the innermost coordination sphere, spin coupling
with uncoordinated "outer sphere" waters can superimpose significantly on the overall T1 relaxation
rate. For reference, Lauffer outlines a general outer sphere model that is applicable to certain high
symmetry scenarios, as follows:
1 [CWNsYIY~s hz
ris 1,o S(S + 1) d3Tr Y [71(&)s, TD, Tle) + 31(&, CD,Te)] (3).T1,os - d -D I
In this expression, the two frequency dependent terms are spectral density functions describing
nuclear and electron scalar and dipolar coupling. As it relates to work described herein, the outer
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sphere contributions also depend directly on S(S+1). Therefore, the total spin of paramagnetic ions has
a direct effect on T1 relaxivity in both directly coordinated and nearby diffusing waters. Outer sphere T1
relaxivity also depends inversely on the distance of closest approach of water protons to the
paramagnet, d, and on the self-diffusion time constant, TD = d 2 /3(DI + Ds) , of nearby waters, based
on the diffusivity of water D,, and that of the contrast agent, Ds.
Small paramagnetic ions are not often employed for transverse (T2) relaxation enhancement in
biological context, since the background T2 relaxation times are already quite rapid (<100 ms) in tissue,
whereas T1 times in tissue are significantly longer (~1 second). T2 contrast agents are more typically
superparamagnetic iron oxide nanoparticles that have substantially larger magnetic moments and, thus,
larger r2. For these more magnetized species, effects on uncoordinated nuclear spins in the so-called
"outer sphere" become important in T2 relaxivity enhancement, and it is generally accepted for small
particles that this process is dominated by the acceleration of transverse dephasing as protons diffuse
through the heterogeneous local magnetic fields of the contrast agent [33]. However, generally
validated theory to describe T2 relaxation enhancement of small superparamagnetic nanoparticles as a
function of applied field and temperature is still an active field of inquiry, although great strides have
been made in recent years by the Belgian researchers Roch, Muller, Gillis, and Gossuin among others
[28,29,34]. For outer sphere effects, it is reasonably well understood that T2 relaxivity of
superparamagnetic nanoparticles depends strongly on their magnetic moment, y, on the diffusion
timescale of water molecules, rD, within the resulting local magnetic field gradients, and on the echo
time used for imaging.
Basing our methods on these theoretical underpinnings, our ambition is to develop MRI contrast
sensors with variable contrast using protein as our material substrate. Therefore, we are primarily
interested in understanding and engineering metalloproteins that confer contrast enhancement,
especially in a manner that could be varied by biochemical events. To do so, we turn our attention to
the mechanisms by which we might modulate physicochemical parameters that govern the contrast
enhancement of natural or engineered metalloproteins in a manner that is sensitive to specific
biomolecules of interest.
1.4.3 Biochemical modulation of relaxivity enhancement
Among the various parameters in the inner sphere component of SBM theory, only a few can be
dynamically modulated by chemical interactions in the context of biological systems. Since relaxation
effects are a linear function of contrast agent concentration, several groups have sought to take
advantage of the parameter Pm, the mole fraction of contrast media, using genetic means-that is, by
exploiting a biological process to modulate the concentration of a contrast agent [35]. For instance,
Koretsky and colleagues have demonstrated that the paramagnetic ion Mn2 can act as a Ca2+ analog and
accumulate in active brain structures in vivo [36,37]. However, perturbations brought about by
exploiting mass transport, pharmacokinetics, or gene expression in a manner resulting in large
concentration changes-on the order of 10- - 10-4 M-are generally quite slow in biological context-on
the order of minutes to hours, if not longer-limiting the utility of such processes for observing rapid
temporal dynamics [35,38].
Alternatively, other approaches to regulate relaxivity of contrast agents directly have been
proposed. Since inner sphere longitudinal relaxation is governed by the coordination of water directly
to the paramagnetic ion, the number of water coordination sites, q, is an overriding parameter for inner
sphere relaxation. To exploit this mechanism, synthetic small molecule T1 sensors for Ca2+ and Zn2+ have
been synthesized, in which selective chelation of the target inorganic ion regulates q on a coordinated
paramagnetic ion, Gd(Ill) or Mn(Ill) [39,40,41]. However, it has not yet been demonstrated that this
class of synthetic compounds is deliverable in vivo at the concentrations necessary for functional sensing
of normal activity (approximately 10 - 100 pM) [14].
Species conferring strong T2 relaxation enhancement are typically superparamagnetic
nanoparticles containing thousands of iron atoms [42]. Efforts to regulate this contrast enhancement
have focused on the effects of clustering or aggregation [34,43]. It has been observed that the
transverse relaxation rate, R2, of clusters exhibits a biphasic relationship dependent on the self-diffusion
timescale of nearby water, rD, and on the echo time used for imaging [44]. For smaller aggregates, this
effect is essentially a second-order function of the aggregate radius [34].
This effect has been exploited to produce a variety of T2 contrast sensors based on synthetic
superparamagnetic nanoparticles. For example, Perez et al. demonstrated that aggregation of
superparamagnetic nanoparticles could be mediated by specific interactions with DNA and protein [43].
Furthermore, Atanasijevic et al. demonstrated that nanoparticles can be inducibly aggregated by Ca , in
a manner that can be tuned using the biochemical parameters of the immobilized protein species
calmodulin (CaM) and its calcium-dependent binding partners [45]. However, since stoichiometry of the
sensor components is critical to the aggregation response of this class of sensors, application in vivo
would require tight control over the pharmacokinetics of each component to maintain them at an
appropriate ratio for sensing. The synthetic complexity of nanoscale devices is typically cumbersome,
and production of large quantities of functionalized nanoparticles for application in vivo is costly and
time-consuming.
1.4.4 A protein engineering approach
Genetically encodable biochemical reporters and sensors have seen substantial success in
fluorescence imaging modalities, an approach pioneered by Tsien, Miyawaki, and colleagues [6].
Genetic encodability presents the opportunity to target precise cell types, structures, and processes by
taking advantage of viral and transgenic technologies [11,46]. Furthermore, enzymology and structural
biology have produced a detailed understanding of the metalloproteins involved in diverse biological
processes. Such mechanistic and structural knowledge can be employed in the process of rational
device design [47], and evolutionary protein engineering approaches can then be exploited to refine
desirable characteristics of the device using the tools of molecular biology [48,49].
To generalize, fluorescent protein sensors operate by perturbing fluorescence signal with
specific allosteric binding events and conformational changes. An analogous approach to modulate
proton relaxation contrast mechanisms could enable new technological possibilities for the magnetic
resonance imaging modality. Along these lines, Shaprio et al. have demonstrated that the hemoprotein
cytochrome P450 BM-3 has ligand-dependent q-and therefore T1 relaxivity-and can be engineered to
bind small molecules of interest to neurobiology [50], which we will discuss in greater detail as it
pertains to Chapter 3. In this recent work, the authors selected dopamine-binding mutants by directed
evolution, and rational site directed mutagenesis was then employed to improve thermostability. When
bound to target ligand, engineered protein variants appeared to have q = 0, whereas unbound proteins
had q = 1 (Figure 2a). The associated T1 relaxivity change has been used to observe potassium-
stimulated dopamine release in cultured cells and in vivo (see Chapter 3).
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Figure 2. Device designs for MRI contrast sensors for soluble analytes. (a) Ligand (red) binding
occludes water coordination at a paramagnetic ion, as in the cytochrome P450 BM3-based sensor
reported by Shapiro et al. [50]. (b) Ligand (red) binding regulates clustering (aggregation) of
superparamagnetic species in two populations, each carrying a binding parter whose interaction is
ligand-dependent, as in the ferritin-based phosphorylation sensor reported by Shapiro et al. [51] and the
functionalized nanoparticle-based calcium sensor reported by Atanasijevic et al. [45].
Only one metalloprotein with a reasonably strong T2 relaxation effect has received substantial
validation as an MRI contrast agent: the iron storage protein ferritin (Ft) [52,53,54]. Proteins in the
ferritin family nucleate and catalyze the formation of a ferrihydrite species containing several thousand
iron atoms in the core of a cage-like protein multimer [55]. Iron-loaded ferritin shows a surprisingly
linear relationship between r2 and applied magnetic field strength [56]. By analogy to the clustering-
induced relaxivity enhancement observed for superparamagnetic nanoparticles [34], the observation
that ferritin relaxivity in tissues is substantially higher than free suspensions of ferritin in solution has led
to the hypothesis that tissue ferritin may be aggregated into clusters [57]. That possibility has already
been exploited both to study the nature of ferritin's relaxation enhancement in tissues [57] and to
engineer a molecular fMRI sensor for protein phosphorylation [51], which will be discussed in greater
detail in the next chapter (Figure 2b).
Accordingly, techniques from molecular biology and protein biochemistry present the
opportunity to engineer arbitrary gains-of-function into natural metalloproteins. Based in on a
theoretical understanding of NMR relaxation processes, we have introduced novel properties into
natural metalloproteins to produce two platforms for developing molecular contrast sensors. The
following chapters detail these efforts and their implications for molecular fMRI.
2 Design and demonstration of a genetically encodable T2 MRI sensor
for Ca2+ dynamics
2.1 Overview
Free calcium is a key intracellular second messenger in neural signaling, governing rapid
presynaptic neurotransmitter release [58] as well as modulating cell state and synaptic plasticity [59]. In
this work, we have undertaken the design and initial demonstration of a genetically-encoded molecular
fMRI contrast sensor for Ca 2 . The sensor is an engineered two-component device that operates by
reversible clustering of calmodulin-ferritin fusion proteins by a homotetrameric calmodulin-binding
crosslinker based on DsRed. Calcium-dependent aggregation results in accelerated T2 relaxation times in
vitro. A preliminary investigation of sensor component expression in live mammalian cells is also
presented.
2.2 Introduction
Diverse molecular events permit the propagation of information between neurons contacting
one another at a synaptic cleft. As an action potential propagates down a presynaptic neuronal axon,
the induced electrical potential across the axonal membrane causes voltage gated ion channels to open,
allowing a rapid influx of Ca2 ' down its concentration gradient into the cell. The transient rise in axonal
free calcium precipitates a number of specific molecular events resulting in information propagation and
signal modulation. Calcium mediates membrane fusion of intracellular presynaptic vesicles, releasing a
burst of neurotransmitters into the extracellular matrix of the synaptic cleft [59].
Binding of neurotransmitters to specific receptors on the postsynaptic cell membrane transmits
a signal into the downstream neuron [60]. The synthesis of information from binding events at
numerous postsynaptic neurotransmitter receptors is integrated by an intracellular protein signaling
network that serves to modulate the ionic, electrical, molecular, and expression state of the
downstream neuron [61]. For example, some of these intracellular signaling events involve G-protein
coupled neurotransmitter receptors (e.g. NMDA receptors for glutamate) containing cation channels,
whose inward calcium ion flux is modulated by neurotransmitter binding as well as membrane potential
and signaling pathway components [62]. This calcium flux may play a critical role in synaptic plasticity,
the process by which neuronal cell-cell contacts are reorganized and strengthened in learning and
memory [61].
Intracellular calcium dynamics therefore play an integral role in information propagation and
processing in the brain. Several studies have demonstrated the tight temporal coupling between axonal
calcium influx and action potential firing rates in a number of neuronal contexts [63,64,65]. We propose
that calcium dynamics in the brain could be a direct signal of synaptic activity, one far closer
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Figure 3. An aggregation-based contrast sensor for free calcium based on superparamagnetic
nanoparticles reported by Atanasijevic et al.. Two species of iron oxide nanoparticles (diameter = 50
nm) are synthesized with surface-immobilized calmodulin or a calmodulin-binding peptide, RS20, which
interact in the presence of Ca2*. (a) Ribbon diagram of the structural interaction between calcium-bound
calmodulin (pink) and RS20 (green), derived from a crystal structure of the complex. (c) Calcium
titration of aggregate size for sensors with immobilized Xenopus calmodulin mutants with two different
calcium affinities, observed by a chance in transverse relaxivity. (d) T2-weighted MRI of the two sensors
in (c) exposed to calcium at a range of concentrations. Red color indicates faster T2 relaxation rates,
whereas blue color indicates slower rates. Adapted from [45].
To sense changes in free calcium levels, small molecule [66] and protein-based [47,67,68]
fluorescent sensors for Ca2. are already in widespread use. Meade and coworkers have demonstrated a
synthetic T1 contrast sensor, DOPTA-Gd, whose water coordination sites are exposed when chelating
Ca2+ [41]. Interesting insights have also derived from the discovery by Koretsky and coworkers that
paramagnetic Mn2+ could act as a Ca2+ analog and accumulate in highly active brain regions [36,37],
although the kinetics of accumulation are generally too slow to observe dynamic processes of interest
[14]. However, for practical application, both of these methods T-based will require high
concentrations (likely >10 pM) to accumulate at the site of interest.
Alternatively, inducible aggregation of paramagnetic nanoparticles at nanomolar concentrations
enhances their T2 relaxivity [43,69], and therefore calcium-inducible nanoparticle aggregation could be a
practical mechanism to generate a sensor whose T2 relaxivity varies with calcium concentration (Figure
2b). Atanasijevic et al. have recently demonstrated such an aggregation-based T2 sensor for Ca2+ by
mixing two populations of ~50 nm iron oxide nanoparticles, where each population displays either
calmodulin (CaM) or calmodulin-binding peptides (CBP) on its surface (Figure 3) [45].
Practical application of such a multicomponent aggregation device in vivo would benefit from
reengineering of the device for genetic encodability. Target cell machinery could supplant manual
synthetic chemistry in producing the sensor, and genetic regulatory mechanisms could be tuned to
directly govern desirable pharmacokinetics. Indeed, viral and transgenic methods to target specific cell
types in the brain have been developed [11]. Furthermore, several genetically encoded calcium sensors
based on fluorescent proteins have been demonstrated in live cells [47,67,70] and in vivo [68], taking
advantage of the calcium-dependent interaction between CaM and a small alpha helical calmodulin
binding domain, M13, to regulate the folding of a fluorescent protein or the F6rster efficiency of energy
transfer between two fluorescent proteins.
To produce genetically encodable paramagnetic nanoparticles, we turned to ferritins, a family of
highly conserved cage-like protein complexes that sequester and oxidize free Fe2+, and store iron in a
hydrated iron oxide particle core [55]. Vertebrate ferritin is a 13 nm 24-subunit heteromultimer
consisting of heavy (~21 kDa) and light (~19 kDa) chains whose relative stoichiometry vary in a species-
and tissue-dependent manner [71]. Ferritin light chains (FTL) appear to nucleate the deposition of iron
oxide grains in the form of ferrihydrite, with a variable stoichiometry often denoted as FeOOH. The iron
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core tends to show asymmetrical geometry by TEM, with a maximal diameter of about 8nm containing
up to ~4500 Fe atoms. Heavy chains (FTH) exhibit ferroxidase activity and appear to enhance the
kinetics of deposition [72].
Iron-loaded ferritin is weakly paramagnetic at room temperature, exhibiting a T2 relaxivity of
about 0.8 mM1 s at 4.7 T [73]. Genove at al. have demonstrated that inducible ferritin overexpression
from an adenoviral vector enhances T2 contrast of both transformed human cells in culture and of
adenovirally-infected mouse brain tissue in vivo [74]. Cohen et al. also recently reported tissue-specific
inducible in vivo ferritin overexpression in transgenic mice and an associated acceleration in T2
relaxation rates [52,53,74]. Furthermore, in vitro aggregation of ferritin induced either by limited
proteolysis [57] or chemical crosslinking [75] enhances T2 relaxivity of purified ferritin in vitro.
Shapiro et al. recently reported an MRI sensor based on phosphorylation-dependent
aggregation and T2 contrast enhancement of recombinant ferritin fusion proteins. Mixtures of two
separately-prepared populations of modified ferritin heteromultimers could be induced to aggregate by
PKA activity, where each population of ferritins incorporates human ferritin light chain (LF) fusions of
either the PKA substrate domain KID or its cognate binding domain KIX [51]. Since the KID/KIX
interaction is bimolecular, two otherwise identical ferritin fusions had to be produced, each carrying half
of the molecular sensor-either KID or KIX (Figure 4a). For this reason, despite being genetically
encoded, both components of Shapiro et al.'s kinase activity sensor cannot be productively encoded
within the same cell. Simultaneous coexpression of these component subunits would result in a
population of ferritins displaying both surface components (Figure 4b). Aggregation of such a species











Figure 4. Design of a genetically-encoded contrast sensor for PKA phosphorylation activity based on
ferritin. (a) Five constructs form the basis for the contrast sensor: PKA substrate KID fused to ferritin
light chain (LF), FLAG-tagged LF for purification, untagged LF and ferritin heavy chain (HF), and the pKID-
binding partner KIX fused to ferritin light chain. A subset of four constructs, with either KID-LF (blue) or
KIX-LF (orange), were cotransfected into a population of HEK293 cells, and the separately purified
recombinant proteins were mixed and assayed for phosphorylation-dependent aggregation. Adapted
from [51]. (b) Thought experiment of the resultant mixed-KID/KIX sensor and unproductive
phoshphorylation response if all five ferritin-based constructs were cotransfected into a single cell
population.
Accordingly, we have built upon the design strategies of both the aforementioned nanoparticle-
based Ca2+ sensor [45] and the genetically encodable ferritin-based kinase activity sensor [51] to
produce a simplified aggregation device to sense intracellular Ca2+ levels by T2-weighted MRI. In
particular, we have introduced a novel "crosslinking" design strategy to allow all sensor components to
be synthesized within the same cell.
...............  .....................  
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2.3 Design
To sense Ca , we took advantage of the interaction between calmodulin and a calmodulin-
binding peptide, dubbed RS20, which derives from a regulatory domain of myosin light chain kinase
(Figure 3a) [45]. It has been demonstrated with a modified version of the fluorescent Ca2+ sensor
pericam that a free two component sensor based on such a calmodulin-peptide interaction can sense
calcium in live cells, despite potential intracellular cross-reaction with endogenous calmodulin and
calmodulin-binding domains [47]. As mentioned, Shapiro et al. also recently demonstrated that N-
terminal fusions to human ferritin can operate as functional aggregation-based T2 sensors [51].
To allow all sensor parts to be synthesized in the same cell, we designed a non-ferritin
homomultimeric "crosslinker" that can inducibly aggregate a homogenous population of ferritins. As a
homomultimeric carrier protein for RS20, we sought an obligate multimer with rich literature resources
regarding stability, expression, and suitability for generation of fusion proteins. DsRed-Express is a red
fluorescent protein variant derived from the coral Discosoma sp. that fits the aforementioned criteria.
Many DsRed variants appear to be stable tetramers in solution [76,77] and have been crystallized as
such [78]. Fusion proteins have been produced from DsRed-Express for use in culture and in vivo [79].
In the sensor presented here, RS20 has been fused to the C-terminus of DsRed-Express, connected by a
short flexible linker sequence (See Methods).
Accordingly, we examined the viability of the device depicted in Figure 5, which consists of two
components: (A) calmodulin-ferritin (CaM-Ft) fusion protein and (B) an RS20 homomultimer that could




Figure 5. Design of a genetically encoded contrast sensor for free calcium based on crosslinkable
ferritin. Calmodulin (CaM) fused to the N-terminus of ferritin (Ft) can be reversibly aggregated in a
calcium-dependent manner by an engineered multivalent crosslinker consisting of homotetratmeric
DsRed-Express fused to a calmodulin-binding domain, RS20.
2.4 Results
2.4.1 A calmodulin-ferritin fusion protein can be synthesized in E. coli when coexpressed with
untagged heavy chains
A mammalian expression construct encoding a calmodulin-ferritin light chain fusion protein with
a short intervening linker was generated by M. Shapiro in the course of his recent dissertation research,
and this construct was generously contributed to the work presented here. It has been observed that




iron loading than homomultimeric light chain human ferritin (FtL) [81]. A CaM-FtH fusion protein was
therefore generated, as depicted in Figure 6, in order to compare the properties of FtH and FtL fusions.
Calmodulin
/ . .,CBP
T7 or CMV i.e.
---- iHHHHHH
Calmodulin FtH / FtL
T7 or CMV i.e.
Ferritin
Figure 6. Design of a CaM-ferritin fusion protein and expression constructs. (a) Cartoon of the
predicted structure of CaM-ferritin based on crystal structures of the two species, indicating the location
of a calmodulin-binding peptide (CBP, red) that is similar to RS20 associated with calcium-bound CaM.
(b) Cartoon of the bacterial and mammalian ferritin expression constructs generated in this work. CaM-
FtH or CaM-FtL fusion proteins were generated with an N-terminal polyhistidine (His6) purification tag,
followed by Xenopus CaM and full length human FtH or FtL sequences described elsewhere [45,51].
Human FtH was also coexpressed in an untagged form during bacterial and mammalian expression.
Expression was under the IPTG-inducible control of a Lacl-repressed T7 polymerase promoter in
bacterial constructs and under control of a strong constitutive cytomegalovirus (CMV) early-
intermediate (i.e.) enhancer/promoter in mammalian constructs.
Since recombinant ferritins are expressible as soluble protein from E. coli, both bacterial and
mammalian expression constructs were generated for N-terminally His6-tagged CaM-FtH and CaM-FtL,
as well as full length unmodified wildtype human FtH (see Methods). For bacterial constructs, a pET-
based expression plasmid with an IPTG-inducible T7/lacl promoter/repressor system was constructed by
standard methods. The CaM-FtH construct was then subcloned into a mammalian expression vector
containing a cytomegalovirus (CMV) early/intermediate promoter-enhancer for high-level constitutive
expression in mammalian cells. The CaM-FtH or the untagged FtH construct were inserted between the
CMV promoter and a downstream IRES site, which could drive bicistronic expression of neomycin,
hygromycin, or puromycin selection cassettes for future stable transfection in mammalian cells).
For in vitro experiments, it was found that bacterially expressed ferritins could be rapidly loaded
with iron in clarified lysate by a room-temperature titration in which drop-wise 100 mM ferrous
ammonium sulfate was added until no color change was apparent while maintaining pH > 8.5 with drop-
wise 1M sodium hydroxide. After overnight incubation at 40C, neutralized lysate containing expressed
ferritins composed of untagged FtH coexpressed with either His6-CaM-FtH or His6-CaM-FtL were purified
by affinity chromatography using a standard procedure.
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Figure 7. Recombinant CaM-ferritins can be bacterially expressed and migrate natively as a single
species. (a) Purified proteins were separated by SDS-PAGE using a 4% stacking and 12% resolving gel
and stained with Commassie Brilliant Blue G-250. Samples were boiled at 95'C for 10 min where
indicated. (b) Expressed CaM-ferritins were loaded with iron in bacterial cell lysates with titrated
ferrous ammonium sulfate (FAS), and the purifed ferritins and commercial horse spleen ferritin (hsFt)
were separated on a native 7.5% PAGE gel in a 50 mM imidazole-HEPES pH 7.6 running buffer. The gel
was photographed without staining.
............. 11 
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The purified protein was separated by SDS-PAGE and visualized by Coomassie G-250 Brilliant
Blue staining (Figure 7a). Since wildtype ferritin is relatively stable in SDS, unboiled samples show a high
molecular weight smear (>>250kDa) of Coomassie stained material in the 4% polyacrylamide stacking
layer that is too large to enter the 12% resolving layer (Lane 3). When samples are boiled in reducing
SDS sample buffer, this high molecular weight material decomposes into two dominant bands
corresponding to the predicted molecular weights of the CaM-Ft fusion protein (39.7 kDa for CaM-FtL
and 40.9 kDa for CaM-FtH) and untagged FtH (21.6 kDa, Lane 1). In Figure 7a, it is also apparent that
homomultimeric CaM-FtL alone shows lower SDS stability without coexpressed untagged FtH, since a
nontrivial band of free CaM-FtL monomer is visible in the unboiled case (Lane 4). Finally, since ferritins
are purified from lysate by affinity chromatography for the N-terminal polyhistidine tag of the CaM-Ft
fusions, the appearance of a copurified band corresponding to the molecular weight of untagged FtH
(21.6 kDa) indicates that native CaM-ferritins are properly a mixture of affinity tagged and untagged
ferritin subunits at a ratio of 1.99:1 by densitometry (Lane 1).
The folding of heteromultimeric CaM-ferritins was assessed by separating purified CaM-FtH/FtH
or CaM-FtL/FtH by native PAGE in a near-neutral (pH 7.6) running buffer and by directly observing the
unstained native color of the ferritin iron core (Figure 7b). Both CaM-FtH/FtL and CaM-FtH/FtH run as
single band toward the positive electrode, indicating that the species has an acidic isoelectric point and
that ferritins are likely to be natively folded as an unsegregated species in solution.
3000
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Figure 8. Bacterially expressed heteromultimeric CaM-ferritins consisting of untagged FtH show
maximal iron loading. CaM-ferritins were loaded in lysate by titrating FAS and sodium hydroxide prior
to Ni-NTA purification and gel filtration. Purified protein was quantified using protein assays, and iron
content was quantified using the Fe(Il)-chelating dye ferrozine in CaM-ferritin samples digested with
sulfuric acid and reduced with thioglycolic acid. Error bars, where indicated, denote standard deviations
of results from three independent preparations.
The extent of iron loading for heteromultimeric and homomultimeric CaM-ferritins was assayed
colorimetrically with Fe(II)-binding dye ferrozine, following proteolytic hydrolysis and reductive
solubilization of core iron. Given concentrations determined by colorimetric protein assays, we
calculated that in vitro iron loading of heteromultimeric CaM-FtL/FtH and CaM-FtH/FtH were essentially
equivalent at ~2400 atoms Fe/Ferritin, showing substantially improved iron loading compared to
homomultimeric CaM-FtL or CaM-FtH alone (Figure 8). We opted to work primarily with CaM-FtH/FtH,
since both heteromultimeric CaM-ferritins seemed biochemically equivalent based for our purposes.
..................... . ....
2.4.2 A tetrameric DsRed-RS20 fusion protein can be synthesized in E. coli and self-associates
a b
T7 or CMV i.e.
--- 1HHHHHH
DsRed-Express RS20
Figure 9. Design of a homotetrameric DsRed-RS20 fusion protein and expression constructs. (a)
Cartoon of the predicted structure of DsRed-RS20 based on crystal structures of the two species,
indicating homotetrameric DsRed in red and the RS20 calmodulin-binding domain in blue. (b) Cartoon
of the bacterial and mammalian ferritin expression constructs generated in this work. DsRed-RS20
fusion proteins were generated with an N-terminal polyhistidine (His6) purification tag, followed by
DsRed-Express and the calmodulin-binding domain (RS20) derived from smooth muscle myosin light
chain kinase [82]. Expression was under the IPTG-inducible control of a Lacl-repressed T7 polymerase
promoter in bacterial constructs and under control of a strong constitutive cytomegalovirus (CMV) early-
intermediate (i.e.) enhancer/promoter in mammalian constructs.
The crosslinking component of the sensor is a DsRed variant C-terminal fused to the calmodulin-
binding peptide RS20. To maximize expression in E. coli, this construct was based on RFP(EC2), an "E.
coli optimized" variant of DsRed containing several mutations in the first nine amino acids, most of
which are silent and are likely to improve ribosome binding site accessibility on transcripts in E. coli [83].
An N-terminal His6 tag and a C-terminal RS20 sequence with codons optimized for both E. coli and
mammalian expression were appended to full length RFP(EC2). As above, the construct was cloned in
the context of a T7/lacl expression system for bacterial expression and then subcloned into a
mammalian expression vector between a constitutive CMV early/intermediate promoter-enhancer and
a downstream internal ribosome entry site (IRES), followed by either neomycin or hygromycin selection
cassettes (Figure 9).
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Figure 10. Recombinant DsRed-RS20 can be bacterially expressed and self-associates. (a) Expressed
proteins were affinity purified and separated by SDS-PAGE using a 12% resolving gel, photographed
under UV illumination (left) or stained with Commassie Brilliant Blue G-250 (right). Samples were boiled
at 950C for 10 min where indicated. (b) Purified DsRed-RS20-1.1 (R17D linker mutant) appears
tetrameric by DLS in HBS buffer. Error bars indicate standard deviations from three separate
measurements.
Bacterially expressed DsRed-RS20 was purified from lysate under denaturing conditions.
Unboiled and boiled samples of the purified protein were separated by SDS-PAGE, and the resulting gel
displayed a band containing a red fluorescent species with an apparent molecular weight consistent
with that of a dimer, 61 kDa, of the desired species (Figure 10). Upon boiling, the band denatures into a
single nonfluorescent band whose migration is consistent with the 30.6 kDa calculated molecular weight
for the desired DsRed-RS20 fusion protein in monomeric form. Finally, dynamic light scattering of the
native protein reveals a hydrodynamic radius RH= 4.76 ± 0.02 nm (mean ± S.D.) in HEPES buffered saline
(HBS) which corresponds to a globular molecular weight of 129 kDa. This size is consistent with the
predicted molecular weight, 123 kDa, of a species consisting of four 30.6 kDa monomers. We have
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dubbed this engineered protein DsRed-RS20-1, to do denote the initial version of this tetrameric
protein.
2.4.3 Recombinant sensor components reversibly aggregate and accelerate T2 relaxation as
a function of calcium concentration, stoichiometry, and crosslinker pI
We sought to examine the behavior of mixtures of purified DsRed-RS20-1 and CaM-ferritin in
vitro in the presence and absence of Ca 2 . All in vitro aggregation studies were done in a HEPES buffered
saline and a low concentration of EDTA (500 iM) to chelate trace free calcium in the basal state. Several
stoichiometric ratios of the interacting functional groups CaM:RS20 were examined for calcium-
dependent aggregation both by dynamic light scattering (DLS) and T2-weighted MRI in the absence or
presence of 500 iM CaCl 2. For DsRed-RS20-1 (Figure 11a), calcium-specific aggregation was observable
when the CaM:RS20 ratio was 2:1, resulting in a 4.8-fold change in the mean hydrodynamic radius.
Ratios showing maximal aggregation were also half-maximally (or worse) aggregated in the absence of
calcium, suggesting that nonspecific hydrophobic or electrostatic interactions were dominating protein-
protein contacts, especially when DsRed-RS20 was in excess.
After calculating the theoretical isoelectric points of the components (monomeric CaM-FtH pl =
4.9, FtH pl = 5.4, and DsRed-RS20-1 pi = 9.1), we hypothesized that electrostatics were playing a role in
nonspecific aggregation. Accordingly, two charge mutants of DsRed-RS20-1 were generated, R17D
(DsRed-RS20-1.1) and K249E (DsRed-RS20-1.2), with the goal of slightly lowering the pl of the fusion
protein. A double mutant R17D/K249E was also generated (DsRed-RS20-1.3), but it was found to show
negligible improvements over the single mutants and was not scrutinized further (data not shown).
These two mutations were targeted to domain linker regions not known to be functional in the sensor.
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Figure 11. Calcium sensors aggregate and accelerate T2 relaxation rates as a function of Ca2+
stoichiometry, and isoelectric point. (a) Mean intensity weighted DLS radii of aggregates mixed at the
indicated ratios of their functional groups, CaM and RS20, with or without 500 pIM free Ca2+ (EDTA-
buffered) in HBS (10 mM HEPES, pH 7.4, 150 mM NaCl, 500 pAM EDTA). Version numbers refer to linker
variants, where v1.1 and 1.2 have charge mutations R17D or K249E in the His6-DsRed linker or DsRed-
RS20 linker, respectively. CaM-FtH/FtH concentration is 1pM for all samples, as determined by a
colorimetric protein assay. (b) T2-weighted spin echo image of samples from (a) loaded into a 384-well
microtiter plate and imaged with TE = 600 ms and TR = 4 s. (c) Quantification of relaxation rates fit from
30 echos with TE ranging from 20 ms to 600 ms in a single 1.63-mm slice through the multiwell plate at
4.7 T.
Mixtures of CaM-FtH/FtH with both charge mutants of DsRed-RS20 showed substantially
reduced aggregation in the absence of calcium. For DsRed-RS20-1.1, mean radius fold change with








excess of RS20 and 29-fold (454 nm vs. 15.9 nm) at 1:2 excess of R20 (Figure 11a). Both charge mutants
exhibit robust aggregation upon incubation with calcium. However, the DsRed-RS20-1.1 mutant shows
the best specificity across all tested stoichiometries of the two components. Uniquely, DsRed-RS20-1.1
even exhibits a 5-fold (68.7 nm vs. 13.4 nm) change when CaM is in 5-fold excess (5:1 CaM:RS20 ratio).
DsRed-RS20-1.1's propensity to aggregate CaM-ferritins is therefore highly robust to the relative
stoichiometry of the two sensor components. It is conceivable that this crosslinker variant's reduced
electrostatic attraction to CaM-ferritin results in decreased avidity for intramolecular crosslinking when
the crosslinker is no longer in excess.
For all three variants of the DsRed-RS20 crosslinker, we examined whether light scattering
results are mirrored by a calcium-dependent change in contrast by T2-weighted 'H MRI of a multiwell
plate filled with sensor mixtures in a range of relative stoichiometries of the two sensor components. A
single T2-weighted spin-echo intensity image at TE = 600 ms and TR = 4000ms shows a dramatic contrast
difference between calcium-treated and untreated samples (Figure 1lb). Relaxation time constants
(1/T2) were fit from the signal intensities obtained from 30 echoes (TE = 20 ms intervals, TR = 4000 ms)
in a multi spin multi echo (MSME) pulse sequence at 4.7 T in a single 1.63 mm slice across the multiwell
plate. The percent change in relaxation time constant between the calcium-negative and calcium-
positive (Figure 11c) was maximal at 26% for DsRed-RS20-1 at a CaM:RS20 ratio of 1:5, whereas signal
change was maximal at a ratio of 1:2 for the charge mutants DsRed-RS20-1.1 (62%) and DsRed-RS20-1.2
(63%). It is worth noting that some trends do not match precisely between the scattering data and T2
relaxometry. For example, DsRed-RS20-1.1 incubated at a 1:5 ratio shows the largest aggregates by DLS,
but apparently shows T2 brightening (lower r2) by MRI. This observation would be consistent with
aggregation beyond the static dephasing limit into an echo time-limited "slow motion regime," such that
further increases in the diffusional correlation time, TD, result in decreases in r2 [44].
Kinetics and reversibility of calcium-dependent DsRed-RS20-1.1/CaM-Ft aggregation were
examined under nonequilibrium conditions (Figure 12). Calcium or EDTA solutions were added where
indicated, and the scattering intensity and fit radius were monitored over time. Aggregation was found
to be rapid, reaching equilibrium scattering intensity on a timescale of approximately two minutes for
micromolar concentrations, while higher calcium concentrations induced faster aggregation, as
expected. Disaggregation appeared to be nearly instantaneous within the resolution of this experiment
on treatment with the chelator EDTA.
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Figure 12. Calcium sensor aggregation is rapid and reversible. Species were added to 1 lpm CaM-ferritin
in HBS buffer at the indicated times and DLS scattering intensity was monitored continuously. DsRed-
RS20-v1.1 crosslinker was added at t = ~95 s in a ~1:2 CaM:RS20 ratio. Blue-background regions indicate
when Ca 2+ is in excess over EDTA.
Since it showed the best aggregation characteristics of the three variants we examined, we
chose to focus on the DsRed-RS20-1.1 variant as the crosslinking component of our sensor. Accordingly,
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the sensor described from here onwards consists of the components in Table 1, except where otherwise
indicated.
2.4.4 DsRed-RS20-1.1 crosslinker-mediated CaM-ferritin aggregation is robust to the
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Figure 13. Calcium sensors aggregate in the presence of 293 cell lysate as a function of Ca2+ and
component stoichiometry. Mean intensity weighted DLS radii of aggregates mixed at the indicated
ratios of their functional groups, CaM and RS20, with or without 500 pIM free Ca2+ (EDTA-buffered) in
HBS. Version numbers refer to linker variants, where v1.1 and 1.2 have charge mutations R17D or
K249E in the His 6-DsRed linker or DsRed-RS20 linker, respectively. CaM-FtH/FtH and 293 cell lysate
concentrations werellpM and ~10 mg/mL, respectively, for all samples, as determined by a colorimetric
protein assay.
To probe whether intracellular proteins might disrupt sensor function in cell cytosol, we
examined the effect of adding detergent-free mammalian cell lysate to the aggregation reactions
detailed in Section 2.4.4 (Figure 13). Transformed human embryonic kidney cells (HEK293H) were lysed
by repeated freeze-thawing, clarified, and filtered to eliminate large protein complexes that would
interfere with scattering measurements. The filtered lysate at ~10 mg/mL alone showed a mean RH= 76
nm in the presence of 100 lpM EDTA, and this background size did not increase substantially on addition
of CaM-ferritin, CaM-ferritin with 1 mM calcium, or CaM-ferritin with DsRed-RS20-1.1 (CaM:RS20 = 1:2)
in the absence of calcium. Mixtures of all sensor components in the presence of lysate and calcium,
however, showed increases in mean radius to 122 nm (1:2) and 311 nm (1:5), which appeared to
disaggregate upon treatment with EDTA.
Component Function N-Terminus C-Terminus Multivalency Multimerization
CaM-ferritin T2 Contrast, Calmodulin H-Chain Ferritin ~14 Hetero (with
Ca2+ Sensing (FtH) untagged H-chain)
DsRed-RS20-vl.1 Crosslinker DsRed- RS20 4 Homo
Express
Table 1. Engineered components of a T2 calcium sensor.
2.4.5 CaM-FtH/FtH expression accelerates T2 relaxation rates of transiently transfected
human lung adenocarcinoma cells
To begin assessing the viability of intracellular expression of sensor components, constructs for
CaM-FtH, untagged FtH, and DsRed-RS20-1.1 were subcloned into mammalian expression vectors. T2
contrast enhancement from overexpressed ferritin in cultured human lung adenocarcinoma A549 cells
has recently been reported [74]. In this work, the authors found that ferritin overexpression conferred a
significant contrast enhancement only after media supplementation with the Fe(llI) source ferric
ammonium citrate (FAC). This result suggests that iron uptake by A549 cells is sufficient to load a
quantity of iron into overexpressed ferritin, although a precise quantification of ferritin iron saturation





Figure 14. Transiently transfected A549 lung adenocarcinoma cells express recombinant CaM-ferritin
and exhibit accelerated T2 relaxation rates. Transverse (1/T2) relaxation rates of pelleted A549 cells
washed in HBSS 48 hr after transiently transfection with FtH alone or cotransfected with CaM-FtH/FtH.
Cell medium was supplemented with 100 [M ferric ammonium citrate (FAC) and 100 mg/mL
holotransferrin where indicated. Inset: T2-weighted MRI intensity image of a 1.63-mm slice across the
multiwell plate at 4.7 T, TR = 4 s, TE = 140 ms (bottom-left: untransfected control, bottom-right:
unsupplemented FtH transfected, top-right: Fe-supplemented FtH, top-left: Fe-supplemented CaM-
FtH/FtH).
We have therefore examined the effects of increased Fe(Ill) in the culture medium of ferritin-
expressing transiently transfected A549 cells. Cells were transfected briefly (2 h) with constitutive CMV
promoter constructs encoding CaM-FtH/FtH or FtH alone and then incubated for 48 h in iron-rich
complete medium (see Methods) where indicated (Figure 14) [84]. Harvested cells were washed
extensively, pelleted in a 384 well plate, and imaged by a T2-weighted spin echo pulse sequence.
Transfection with FtH alone in medium containing 10% serum was sufficient to confer T2 shortening,
although FtH-overexpressing cells treated with iron supplements show substantially faster relaxation
times, as in [74]. Interestingly, coexpression of CaM-FtH and unlabeled FtH appears to result in higher T2
enhancement than FtH alone. One might speculate that differences in subcellular compartmentalization
or expression levels may contribute to this effect. At a minimum, the CaM-FtH fusion protein does not
negatively interfere with iron uptake in A549 cells.
2.4.6 Cells transiently transfected with the sensor show a change in subcellular fluorescence
localization on treatment with a calcium ionophore
Transient transfection of A549 cells with a constitutive construct encoding DsRed-RS20-1.1
resulted in strong intracellular red fluorescence. After 24 - 48 hours post-transfection, fluorescence
appears in both the cytosol and nucleus, with somewhat stronger nuclear signal in cells co-transfected
with CaM-FtH/FtH (Figure 15, t = 0), although heterogeneity in subcellular localization was apparent
across the dish (data not shown). Strong fluorescence signal can be observed in a small number of
punctate cytoplasmic bodies and possibly in nucleoli. Some cells show generally diffuse localization,
with a strong fluorescence signal and poor cell morphology (data not shown). This population
heterogeneity may be due to differences in transfection complex loading, an effect of transfection
toxicity, or cell cycle differences. Generally, cells with intermediate and lower fluorescence intensity
showed normal cell morphology.
In vitro, we observed that calcium-dependent aggregation had no effect on observable red
fluorescence of the sensor for three DsRed-RS20-1 variants across a range of stoichiometries in HBS
buffer (data not shown), perhaps because aggregates are too amorphous for self-quenching or FRET
quenching effects. On treatment with calcium ionophore ionomycin in the presence of high
extracellular Ca2+ [85], cells showed a change in subcellular localization of fluorescence that was
different between those expressing DsRed-RS20-1.1 alone and those co-expressing CaM-FtH/FtH (Figure
15). Specifically, ionomycin treatment
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Figure 15. Subcellular localization of DsRed-RS20-1.1 fluorescence is altered by ionomycin treatment
in live transiently transfected A549 lung adenocarcinoma cells with and without co-transfected CaM-
FtH/FtH. A549 cells were transfected with constitutive DsRed-RS20-1.1 alone (bottom) or with CaM-FtH
and FtH constructs (top) for 24 h washed and imaged in HBSS containing ~11 mM CaC12 and 1mM MgCl 2.
At t = 0, live cells were treated with 2.5 IM ionomycin, a calcium ionophore that chelates and shuttles
Ca 2+ across membranes. Imaging was performed on a compound fluorescence microscope equipped
with a xenon lamp and CCD camera.
2.5 Discussion and Conclusions
In this chapter, I have described an engineered device to sense calcium levels that has been
developed and demonstrated in vitro. The novel contrast agent "crosslinking" design strategy employed
here should be generalizable for making aggregation-based MRI sensors based on any two-component
ligand-inducible protein-protein interaction. Use of such a crosslinker might substantially reduce the
synthetic complexity of sensors based on of superparamagnetic nanoparticles, such as those presented
in Atanasijevic et al.'s calcium sensor.
Having hypothesized that electrostatics play an important role in the sensor's aggregation
specificity, we made rational mutations that resulted in sensor variants that show dramatically low
nonspecific aggregation in the absence of calcium while retaining a significant aggregation response in
the presence of calcium. Aggregation kinetics observed for this sensor variant are sufficiently rapid to
observe calcium dynamics on a timescale of minutes. Initial testing in detergent-free mammalian cell
lysate suggests that intracellular function is plausible in the context of cell proteins, and preliminary
observations of DsRed-RS20-1.1 fluorescence suggest that an intracellular clustering may occur as a
response to ionophore-induced intracellular calcium influx.
It is worth noting, however, that while calcium-dependent sensor aggregation was robust to the
presence of cell lysate, mean radii in Figure 12 were somewhat lower for a given CaM:RS20 ratio in the
presence of detergent-free lysate than observed in the absence of lysate. This suggests that
endogenous cellular components do compete for the CaM-ferritin and DsRed-RS20-1.1 binding sites,
either by specific or nonspecific interactions. However, since the aggregation effect appeared
recoverable when RS20 sites were in higher excess, it is likely that appropriate sensor function can be
achieved intracellularly by tuning DsRed-RS20-1.1 expression to an appropriate excess over CaM-ferritin.
Similarly, Miywaki et al. found that the FRET-based calcium sensor YC2.1 had markedly increased
interaction with free CaM compared to sensors consisting of both CaM and M13, a calmodulin binding
peptide similar to RS20. The authors further hinted at a change in subcellular localization of the split
sensor components upon increases in intracellular calcium [86], an observation that we have also made
with transiently transfected DsRed-RS20-1.1 (data not shown).
Specific interactions with endogenous CaM or CaM-binding proteins may also interfere with
normal cellular function. Further work is necessary to demonstrate the viability of this sensor in an
intracellular context and to tweak the design to overcome likely challenges. For example, mammalian
expression constructs have been generated and confer heterogeneous expression in transiently
transfected cells, but it was not possible to select stable integrated clones from this population. We
hypothesize that the expression levels of this initial CMV promoter construct could be too high for
selection, perhaps due to off-target effects on calcium-regulated processes involved in growth. This
explanation is conceivable in our present design, in which Xenopus calmodulin and MLCK calmodulin
binding domains are incorporated into the two components of the sensor, and it is compatible with the
observation that aggregates are smaller in detergent-free cell lysate for a given relative stoichiometry of
sensor components. However, we believe these challenges can be overcome using a weaker or
inducible promoter system or through either a rational or a screening approach to generate calmodulin
and RS20 variants that have orthogonal binding specificity [87,88].
Ideally, an expression system should be developed to stably express the ferritin component in
tissue culture cells and, ultimately, in vivo. While the DsRed-RS20 crosslinking component could
imaginably be induced when necessary, the utility of the sensor relies critically on the kinetics of iron
loading into CaM-ferritins. A rapid system to manifest iron loading is conceivable in tissue culture, e.g.
by manipulating cellular iron uptake. On the other hand, it will be challenging to manipulate in vivo iron
bioavailability in practical experimental contexts. It seems more plausible that stable constitutive
expression of sensor components over an extended period of time (e.g. using genome-integrating viral
vectors or transgenic animals) could permit sufficient iron loading into overexpressed ferritin.
Since others have observed contrast effects of overexpressed ferritin using inducible expression
systems in cultured cells and in vivo [52,53,74], and since we have also demonstrated iron loading of
transiently transfected CaM-ferritin in cultured cells, we are optimistic that a functional CaM-ferritin
contrast agent could be viably expressed in vivo. Also, we observe robust expression arising from pilot
experiments with transiently transfected DsRed-RS20 in cultured cells. Accordingly, we believe that
adaptation of the all parts of the calcium sensor system for simultaneous expression in tissue culture
cells will be viable in the near future. Further work to assess sensitivity to intracellular calcium dynamics
could then proceed in the desired intracellular context.
2.6 Materials and Methods
2.6.1 Cloning of DsRed-RS20 and CaM-ferritin fusion proteins
Full length human ferritin heavy chain (FtH) and light chain (FtL) were initially cloned into pCMV-
Sport vectors as previously described [45]. Xenopus calmodulin (CaM) was fused N-terminally to FtL
with an intervening GTSSEF linker sequence and was generously provided by Mikhail Shapiro. For IPTG-
inducible bacterial protein expression, CaM-FtL was subcloned into the Ndel/Xhol sites of pET28a
(Novagen), resulting in an N-terminally His 6-tagged construct. CaM-FtH was assembled by excising the
EcoRl/Xhol fragment containing FtL and religating the purified backbone with the corresponding
EcoRl/Xhol fragment from pCMV-Sport-FtH containing full length FtH. FtH was also subcloned for
bacterial expression by excising an Ncol/Xhol fragment from pCMV-Sport-FtH and ligating the fragment
into Ncol/Xhol digested pET16b. CaM-FtH and untagged FtH constructs were Ncol/Xhol sites further
subcloned into mammalian expression vectors pTriEx3-hyg (Novagen) and plRESpuro3 (Clontech),
respectively. All clone selection was performed by transforming ligations into chemically competent
DH5a T1R E. coli (Invitrogen) and plating on selective media. DNA isolated from single clones was
sequenced to verify the construct using a T7 promoter primer (New England Biolabs).
DsRed-RS20 was constructed using the sequence RFP(EC2) produced in the Keasling laboratory
for improved bacterial expression of DsRed proteins [83]. This variant of DsRed-Express contains several
silent mutations in codons 2-4 that the authors suggest may improve translation efficiency. Full length
RFP(EC2) was cloned as an N-terminal fusion to a codon optimized sequence encoding the myosin light
chain kinase (MLCK) calmodulin binding peptide RS20 [45] with an intervening linker sequence GSSKGG.
This fusion was inserted between the Ndel/Xhol sites of pET28a, resulting in an N-terminal His 6-tagged
construct under the control of a T7/lacl promoter/repressor system. The linker between the His6
purification tag and DsRed contains a thrombin protease recognition site (SSGLVPRGSH). An arginine in
this site was mutated to aspartic acid (R17D) using site directed mutagenesis (Quikchange, Stratagene)
to reduce the predicted isoelectric point of the fusion protein, and this variant was designated DsRed-
RS20-1.1. Another charge mutant was also generated (K249E), DsRed-RS20-1.2, which replaces a lysine
in the linker sequence between DsRed and RS20, resulting in the linker (GSSEGG). Finally, a fusion
protein with the two domains in reverse order (N-terminal RS20-DsRed) was produced, but it was found
to have poor expression in E. coli (data not shown). For mammalian expression, an Ncol/Xhol fragment
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containing DsRed-RS20(R17D) was subcloned into pTriEx3-neo (Novagen). All constructs were verified
by restriction digest and sequencing using a T7 promoter primer.
2.6.2 Recombinant protein expression and purification
Sensor components for in vitro assays were synthesized recombinantly in E. coli. Chemically
competent BL21(DE3) pLysS cells (Invitrogen) were cotransformed with constructs encoding FtH and
either CaM-FtL or CaM-FtH. Cotransformants were selected for growth on LB agar containing 50 tg/mL
kanamycin and 100 ig/mL ampicillin. Liquid LB cultures were grown to mid-log phase and induced by
addition of 1 mM IPTG for 4 hours at 30C. pET28-DsRed-RS20 constructs were transformed into
BL21(DE3) Star (Invitrogen) E. coli, and cultures were grown using the same procedure, except induction
proceeded overnight at 300 C.
Induced cultures of DsRed-RS20 proteins were harvested by centrifugation. The highest protein
yield was observed when lysated were generated under denaturing conditions using the Pierce Inclusion
Body Solubilization Reagent, clarified by centrifugation at 16,000 g, and incubated for 2 h at 40C with Ni-
NTA Superflow agarose resin (Qiagen). The resin was then loaded into an empty gravity column and
washed with two column volumes of the solubiliztion reagent, followed by 20 column volumes of a
native wash buffer containing 20 mM imidazole, 50 mM sodium phosphate, pH 8.0, and 300 mM NaCl.
The protein was then eluted in the same buffer containing 250 mM imidazole and desalted by gel
filtration using a PD10 G-25 Sephadex (GE Amersham) disposable column equilibrated in 10mM HEPES,
pH 7.4 with KOH, and 150mM NaCl. Purity was analyzed by SDS-PAGE of boiled or unboiled samples.
Induced cultures of expressed CaM-ferritins were harvested and lysed using a Bugbuster lysis
reagent containing lysozyme and benzonase (Novagen) as per the manufacturers' instructions, with the
addition of an EDTA-free protease inhibitor cocktail at a 1:1000 dilution (EMD Biosciences). Induced
lysates containing ferritin generally show negligible insoluble matter, and therefore clarification is often
unnecessary. Purification proceeded after titrating 100mM ferrous ammonium sulfate drip-wise until
no further color change was observed. Solution pH was maintained >8.5 using 1M NaOH. Lysates were
agitated overnight at 40C and then purified using Ni-NTA agarose resin, as above. Purity was analyzed
by SDS-PAGE separation with Coomassie Brilliant Blue G-250 staining with or without boiling for 10 min
at 95OC in reducing sample buffer. Proper folding of purified ferritin proteins was assayed by native
PAGE in a 50mM imidazole-HEPES running buffer, pH 7.5, and iron-loaded ferritin was visualized by its
native coloring under white light.
Protein concentrations were determined with a bicinchoninc acid (BCA) assay or Pierce 660nm
Protein Assay using either BSA or horse spleen apoferritin (Sigma) as a loading control. Iron loading was
assayed by digesting protein samples at a range of dilutions in H2SO 4 and reducing Fe(Ill) to Fe(ll) using
thioglycolic acid (TGA). Iron concentration was assayed colorimetrically with the Fe-chelating dye
ferrozine (Sigma). For example, 10lpL of protein solution was mixed with 20plL 2M H2SO 4 and 20uL
concentrated TGA (Sigma) and incubated at room temperature for 30 minutes. Solutions were
neutralized by addition of 40ptL 2.5 M sodium acetate and incubated with 20ptL 0.1M ferrozine for 30
minutes further. Samples were then diluted by addition of 750ptL ultrapure water and absorbance at
562 nm was read on a UV/Vis spectrophotometer. Fe(ll) concentrations were calculated using the
ferrozine-Fe(lI) molar extinction coefficient E562nm = 29,700 M1 cm' [89].
2.6.3 Dynamic light scattering (DLS)
Light scattering experiments were performed on a Dynapro DLS system (Wyatt Technologies)
equipped with a temperature controlled cuvette holder maintained at 370C. All measurements were
performed in HEPES-buffered saline (HBS): 10 mM HEPES, 150 mM NaCl, 0.5 mM EDTA, adjusted to pH
7.4 with KOH. Buffers and purified protein samples were prefiltered using 0.2 micron syringe or
centrifugal filters. Mixed samples were loaded into a quartz cuvette which was then equilibrated at the
set temperature for two minutes prior to data collection. To assess equilibrium aggregation state, 10
acquisitions were collected per second for 50 seconds. The manufacturer's software Dynapro reported
a fit mean intensity-weighted hydrodynamic radius, R, by fitting to an isotropic sphere model. For non-
equilibirum kinetics experiments, filtered CaCl 2 or EDTA stock solutions were diluted into mixed protein
samples at indicated intervals, and the solution was quickly mixed by rapid aspiration and expulsion
during the course of uninterrupted acquisition at 1-sec intervals. Note that scattering and transmission
detectors are swamped by external lighting for several seconds while the cuvette door is open during
this process, and therefore no scattering appears during this short interval.
2.6.4 MRI relaxometry
Protein samples at a range of relative stoichiometries were diluted in 0.2 micron filtered HBS
buffer into 384-well microtiter plate wells (BD Falcon), and peripheral plate wells were filled with buffer
alone. Where indicated, deionized water or 1 mM filtered CaC 2 was added such that its final
concentration was approximately 500 ptM, buffered by EDTA. The plate was imaged at room
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temperature in a 4.7 T Bruker Avance animal scanner with a 40cm-bore. Images were taken in a 1.63-
mm slice across the plate using a multi-spin multi-echo (MSME) pulse sequence with the following
parameters. Time to echo (TE) ranged from 20 - 600 ms in 20 ms increments for 30 echoes. Repetition
time (TR) was 4000 ms. Four scans were taken and averaged. T2 relaxation rates were fit from
reconstructed image data using custom routines developed in Matlab (Mathworks).
2.6.5 Mammalian tissue culture, transfection, and ionomycin treatment
Human lung adenocarcinoma A549 cells (ATCC) were cultured at 5% CO2 and 370 C as
recommended by the supplier in Kaighn's F-12K medium (Invitrogen) containing 10% fetal bovine serum
and typical penicillin and streptomycin antibiotics. At 90-95% confluence, cultures were washed and
preincubated for 30-60 min in OptimMEM-1 medium (Invitrogen), followed by transfection with
Lipofectamine 2000 (Invitrogen) by the manufacturer's protocol. After 1.5 - 2 hours, OptiMEM and
transfection complexes were aspirated and replaced with fresh complete growth medium and, where
indicated, 100 iM filter sterilized ferric ammonium citrate. Transfected cells were incubated for a
further 24 - 48 hours prior to microscopy or MRI experiments. Fluorescence microscopy was performed
on cells washed twice in Hank's Balanced Salt Solution (HBSS) containing 1 mM CaCl 2 and 1 mM MgC 2,
to which an additional 10 mM CaCl 2 was added prior to treatment with 2.5 pM ionomycin (Sigma).
3 Toward practical small molecule T1 sensors: Improving the
longitudinal relaxivity of Bacillus megaterium Cytochrome P450
BM3h
3.1 Introduction
Positive contrast agents, those that enhance observable MRI signal, are the optimal mode of
contrast for practical application in vivo since they locally increase the observed signal-to-noise ratio. As
examined in Chapter 1, positive contrast is generally achieved with paramagnetic ions that accelerate
the recovery of longitudinal (T1) relaxation, most often by acting on water molecules coordinated in the
so-called inner sphere [27]. Since molecular rearrangements at inorganic ions have long been known to
effect their solvent coordination, several groups have shown interest in generating MRI sensors that
operate by modulating the number of water coordination sites in the inner sphere. Thus far, such
sensors have been chelates of the paramagnetic ions Gd3+ or Mn 2 . [39,40] which are synthetically
complex and may have downstream biocompatibility challenges [39]. Moreover, modifications of such
synthetic contrast agents to alter their target specificity or optimize other biochemical properties are
technically cumbersome.
Alternatively, our group has explored the possibility that metalloproteins found in nature might
be engineerable substrates for producing T1 sensors with mutable specificity [50]. In principle, such
protein-based MRI sensors should have tunable biochemical properties, tissue distribution,
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pharmacokinetics, and expression patterns that could be optimized through well established molecular
biology techniques that have resulted in pioneering protein-based sensors for optical imaging modalities
[5,87,90,91,92].
Figure 16. Bacillus megaterium cytochrome P-450 BM-3 (CYP102) heme domain (BM3h) ribbon
structure with bound N-palmitoyl glycine (green) and heme (iron protoporphyrin IX, red). PDB code
1JPZ.
For generality to future molecules of biological interest, a suitable metalloprotein platform was
sought for producing such T1 sensors. The bacterial hemoprotein cytochrome P450 BM-3 (EC 1.14.14.1)
is an NADPH dependent monooxyenase with micromolar affinity for various fatty acid substrates (Figure
16) [93]. In an extensive series of publications, the Arnold group at Caltech has demonstrated that BM-3
can serve as a flexible platform for developing a variety of engineered enzymatic reactions [94,95,96].
Shapiro et al. observed that the heme domain of BM-3 (BM3h) has millimolar affinity for dopamine (DA),
a catecholamine neurotransmitter biosynthesized from the amino acid tyrosine. DA is an important
intermediary in a vast range of neurological processes including cognition, reward, and learning [97,98]
as well as in disease states such as Parkinson's [99] and schizophrenia [100]. Crystal structures of the
wildtype hemoprotein exist in both unbound [101] and fatty acid substrate bound conformations [102].
It is apparent from these structures, as well as other optical characterization, that substrate binding







0 1 2 3 4 5
rounds of evolution
PBS AA DA









Figure 17. Directed evolution of an MRI contrast sensor for dopamine. (a) Longitudinal relaxivity (r2) of
wild-type cytochrome P-450 BM3h in PBS with or without saturating concentrations of aracadonic acid
(AA) or dopamine (DA). (b) Longitudinal relaxivity of evolved DA-binding variants 8C8 and B7 from 4th
and 5th round screens, respectively, in the absence or presence of saturating DA (400 IIM). (c)
Progenitor mutant equilibrium dissociation constants for DA and AA for picked variants in each round of
screening. (d) Titration cuves for DA-binding absorbance change for mutants indicated in (c). (e)
Mutation map for color-coded mutants in (c) and (d). Adapted from [50].
Since inner sphere T1 relaxivity is directly proportional to q, the number of water coordination
sites, BM3h appeared to be a natural small molecular T, sensor. To prove this, the authors examined
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BM3h's T1 relaxation rate when mixed with a natural fatty acid substrate, arachidonic acid (AA), and
observed the hypothesized effect (Figure 17a). Then, beginning with the observation that BM3h also
binds DA with low affinity, Shapiro et al. performed an iterative screening and selection procedure to
generate variants with increased affinity for DA and decreased affinity for the fatty acid arachidonic acid
(AA). Over five rounds of evolution, BM3h mutants could be isolated with DA binding affinities in the
micromolar range (Figure 17b). Furthermore, the observed T1 relaxivity of DA-binding BM3h variants
could be tuned from around 1 mM s- (4.7 T) in the unbound state to nearly zero in the presence of
substrate. Complete abolishment of r2 implies that DA-bound BM3h variants have q = 0 [50].
The utility of this contrast sensor to measure DA in biological context was validated both in
tissue culture and in vivo. Potassium stimulated DA release from cultured PC12 pheochromocytoma
cells resulted in a detectable contrast change for DA-binding variants but not for wildtype BM3h.
Furthermore, potassium stimulated DA release could be detected in rat brains by intracranially injected
DA-binding variants but not by contralaterally injected wildtype BM3h [50]. In sum, the authors have
nicely demonstrated the basic utility of initial versions of engineered T1 sensors for extracellular DA.
To advance this platform and to aid its practical utility to addressing interesting questions in
neuroscience, improvements must be made in the sensor's sensitivity to dynamics in low concentration
neurotransmitters. Specifically, detection of low micromolar DA dynamics in reward and learning
processes would benefit from a sensor with higher basal T1 relaxivity, allowing for better sensitivity,
shorter scan times, and reducing the minimum concentration required for sensing.
As mentioned in Chapter 1, T1 relaxation enhancement arises from paramagnetic effects on
coordinated and nearby water protons, in a manner modeled by the Solomon, Bloembergen, and
Morgan equations (see Section 1.4.1). Among imaginable chemical modifications to the protein that
could increase its basal T1 relaxivity, a relatively straightforward approach would be to increase the total
electron spin, S, of its central paramagnetic ion. BM3h's protoporphyrin IX-bound Fe(Ill) is
predominantly low spin (S = 1/2) [104] with a hexacoordinate geometry, an axial cysteine ligand, and a
water in the distal coordination site [101]. While Gd(Ill) would be an excellent choice due to its high spin
(S = 7/2), Gd(Ill) is not bioavailable, might exhibit toxicity [105], and could not be accommodated within
a porphyrin ring. The next best options would be high spin Fe(Ill) (S = 5/2), Mn(II) (S = 5/2), or Mn(lll) (S
= 2). Of these, Mn(Ill) is the most practical option, since it is generally considered to be obligately high
spin and redox stable in biological contexts [106].
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Figure 18. X-ray crystal structure comparison of Mn(Ill) (red) and Fe(Ill) (blue) porphyrin containing
cytochrome P450cam. (a) Substrate free and (b) camphor substrate bound structures are shown
stereoscopically. Adapted from [107].
Since T1 relaxivity is proportional to S(S+1) in SBM theory (see Chapter 1.4.1), the relaxivity of
low spin BM3h could be increased as much as eight-fold by substituting its prosthetic heme group, Fe(Ill)
. ...............   .... 
protoporphyrin IX, for Mn(Ill) protoporphyrin IX (MnPPIX), and assuming that other parameters
influencing r1 are unchanged. Alternatively, relaxivity could be enhanced by as much as 11.7-fold by a
mutant in which the native iron heme prosthetic group stably incorporates high spin Fe(Ill) in a
hexacoordinate geometry with a labile water in the distal position. High spin hexacoordinate
geometries have been observed in other hemoproteins, including aquomet-myoglobin [108], horse
radish peroxidase C bound to benzhydroxamic acid [109], Streptomyces sp. catalase-peroxidase [110], as
well as others. Crystal structures of the closely related camphor monooxygenase cytochrome P450cam
show very minor structural perturbations in the heme binding pocket-distortions that appear to be
within the resolution of the crystal structure (Figure 18) [107].
We therefore hypothesized that MnPPIX substituted BM3h variants would exhibit substantially
enhanced T1 relaxivity in exchange for some perturbation of substrate binding affinity. We believe this
engineered manganese protein will then serve as a high relaxivity substrate for further directed
evolution or rational design of its ligand binding site.
In the remainder of this Chapter, we describe a method to produce high spin MnPPIX-
substituted BM3h variants (MnBM3h) and demonstrate that the relaxivity gain is approximately four-
fold. I demonstrate that in vitro protein refolding has limitingly low efficiency, and we instead propose
an "in vivo" method to generate MnBM3h during protein expression in E. coli. Finally, we will outline
initial efforts in collaboration with the Arnold group to produce a high spin Fe(lll) variant of BM3h.
3.2 Design
Metalloporphyrin substitution is generally performed by in vitro refolding of apoprotein,
primarily by batch dilution, dialysis, or chromatographic methods. Success with these methods varies in
a protein-specific manner, and screening for refolding conditions is a laborious but critical process to
achieve high yields of the desired conformer [111,112].
A method for porphyrin substitution of BM3h has been reported [113]. Recombinant BM3h
with modified ferriporphyrins was generated by acetone/HCI precipitation of apoprotein followed by
reconstitution with modified porphyrins, ion exchange chromatography, and dialysis. However,
thermostability and enzymatic observations arising from control protein refolded with ferric heme
suggests that this method does not properly regenerate the original biochemical characteristics of the
protein. It is conceivable that the harsh conditions necessary to generate apoprotein in the authors'
method might result in protein hydrolysis or sidechain modification. It is also plausible that a
distribution of alternate conformations exists in the refolded product. Nonetheless, we examine the
method in this work as a starting point for in vitro MnPPIX substitution.
Alternatively, bacterial uptake of metalloporphyrins has been demonstrated during recombinant
protein expression in E. coli. In particular, overexpression of the bacterial transmembrane heme
transporter ChuA (ShuA in Shigella) enhances recombinant hemoglobin yield in E. coli supplemented
with exogenous heme [114}. It has also been shown that E. coli overexpressing ChuA incorporate
exogenous metalloporphyrins into coexpressed protein [115], in a manner that can affect cytochrome
function [116]. Similarly, a HemB-deficient E. coli strain, RP523, demonstrates increased heme uptake
through an uncharacterized mechanism (which is likely to be a hypermorphic ChuA allele) and can
incorporate non-iron metalloporphyrins into coexpressed proteins [117].
Due to its HemB deficiency, RP523 requires exogenous heme for growth, resulting in an
induction procedure that involves harvesting and resuspension in a heme-free medium for expression of
non-iron metalloporphyrin substituted proteins. Since high throughput (HT) screening of ligand binding
variants is a long term aim of this work, it would be optimal to avoid such a media change step in HT
format. Accordingly, we opted to clone ChuA from 0157:H7 enterohemmoragic E. coli into a plasmid for
inducible coexpression alongside BM3h.
3.3 Results
3.3.1 BM3h apoprotein can be only partially reconstituted with MnPPIX in vitro
Following published methods [113], BM3h apoprotein was precipitated from holoprotein
dissolved drip-wise in ice cold acetone/HCI and resolubilized in a buffer containing 8M urea. Partial
refolding of apo-BM3h was accomplished by an affinity chromatographic method in which polyhistidine
tagged apo-BM3h was immobilized to a Ni-NTA agarose affinity resin under denaturing conditions. Apo-
BM3h solutions were reconstituted with MnPPIX while diluting to a urea concentration of ~2M prior to
loading on the affinity resin. Protein was then allowed to refold in denaturant-free buffer. Soluble
refolded protein could be eluted with native buffer containing imidazole.
Spectrophotometry of desalted eluate showed a unique blue-shifted Soret peak at 373 nm
which was distinct from that of free MnPPIX (~367 nm) or of the Soret peak (~420 nm) of native iron-
containing BM3h (FeBM3h, Figure 19a). A band with mobility similar to native FeBM3h variants but with
distinct unstained coloring was resolvable by separation on a native polyacrylamide gel (Figure 19b).
However, refolded MnBM3h samples exhibited a substantial amount of Coomassie Blue-stained
material that appeared in a poorly defined low-mobility smear. Furthermore, circular dichroism (CD)
spectra of the samples showed reduced ellipiticity in low wavelengths characteristic of an increase in
random coil structure (Figure 20c). Yield of the desired product was estimated to be roughly less than
5%, suggesting that alternate strategies should be explored for producing MnBM3h in large quantities.
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Figure 19. Apoprotein production and low-efficiency refolding of MnBM3h variants using a
chromatographic in vitro method. (a) UV/Vis absorbance spectra of BM3h-8C8 variant holoprotein
(- -), urea-solubilized apoprotein (----), and MnPPIX substituted sample (-). (b) 7.5% native PAGE
separation of holoprotein BM3h variants (FeWT, FeB7, and Fe8C8), apoprotein, and refolded Mn-
substituted protein. Top: unstained native protein coloring under white light. Bottom: Coomassie
Brilliant Blue G-250 stained. (c) CD spectra of 8C8 holoprotein (--- -) and Mn-substituted protein (-) in
10mM potassium phosphate pH 7.4, 100mM ammonium sulfate.
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3.3.2 BM3h bacterially expressed in iron-free media can be refolded in lysate by addition of
MnPPIX
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Figure 20. MnBM3h protein from expressed apoprotein in E. coil lysates has increased T, relaxivity.
BL21(DE3) E. coli were induced with IPTG to express BM3h in iron-free minimal media, and lysates were
incubated overnight with 50 pg/mL MnPPIX prior to purification. (a) UV/Vis absorbance spectra of wt
BM3h holoprotein (- - ), Mn-substituted protein (-), and free MnPPIX chloride (-.) in PBS. (b) 7.5%
native PAGE separation of holoprotein and purified MnBM3h samples. Top: unstained native coloring
visualized under white light. Bottom: Coomassie Brilliant Blue G-250 stained. (c) CD spectra of lysate
loaded FeBM3h (- - -) and MnBM3h (-) in 10mM potassium phosphate pH 7.4, 100mM ammonium
sulfate. (d) T1 relaxation rates of lysate loaded FeBM3h (e) and MnBM3h (0) in PBS at a range of
concentrations. Linear fits give the indicated relaxivities. Concentrations were determined by a







In place of the harsh HCI/acetone procedure to generate apoprotein from holoprotein used
above, we sought to express BM3h apoprotein directly in E. coli by growth and induction in minimal
media lacking iron. Whole lysates generated from these cells were incubated with MnPPIX and
subsequently purified under native conditions. The resultant protein exhibited an absorbance peak at
382 nm that was distinct from free MnPPIX and native Fe-BM3h protein (Figure 20a). Native PAGE
separation of purified samples revealed a dominant band migrating similarly to Fe-BM3h but with
unique unstained coloring. Furthermore, its secondary structure is nearly identical within the resolution
of our CD instrument (Figure 20b).
MnBM3h produced by this method showed a >2-fold enhancement in relaxivity (3.5 mM1 s1)
over native FeBM3h (Figure 20c). For this measurement, concentration was determined by
standardizing a typical BCA protein assay with native FeBM3h of known concentration (see Methods). It
should be noted, however, that the presence of apoprotein in MnBM3h samples would overestimate
concentrations-and therefore underestimate relaxivity of the Mn(Ill)-containing species. It is apparent
from the Commassie Blue-stained native gel in Figure 20b that some amount of aggregated protein
material is present, most notably visible by blue staining in the sample well. Accordingly, we
hypothesize that this relaxivity measurement underestimates the relaxivity of MnBM3h.
3.3.3 Coexpression of 0157:H7 ChuA with BM3h variants in MnPPIX-supplemented minimal
media results in refolded MnBM3h proteins with improved T1 relaxivity
To improve yield and aide downstream screening procedures, I sought a method to express
MnPPIX substituted proteins during expression in E. coli. Based on others' work seeking to enhance
bacterial production of recombinant hemoproteins [114,115,117] and to analyze metalloporphyrin
effects on respiratory chain function [116], we undertook to coexpress the outer membrane heme
receptor ChuA. The complete ORF was cloned from 0157:H7 genomic DNA into a T7/lacl inducible
promoter/repressor expression system. MnBM3h protein could be produced in high yield from
BL21(DE3) E. coli cotransformed with this ChuA construct and an inducible BM3h expression constructs
were grown in iron-free minimal media and induced in the presence of supplemented MnPPIX (Figure
21a).
The resultant purified protein shows an absorbance peak at 382 nm, which was similar to that
seen for MnBM3h samples refolded in lysate from expressed apoprotein (Figure 21c). Interestingly, the
three MnBM3h variants showed differences in the relative amplitude of the absorbance bands at 382
nm and 519 nm compared to that at 280 nm and to the shoulder at 418 nm. Since these variants were
evolved for distinct substrate binding specificities, one might postulate that they exhibit differences in
their active site conformations and, therefore, in the electronic structure of the MnPPIX coordination
field. Nonetheless, the spectra of all three BM3h variants were wholly distinct from that of free MnPPIX
and from FeBM3h proteins. The three Mn-substituted variants were also migrated similarly to Fe-
containing proteins by native PAGE, showing distinctive unstained color differences between the two
metalloporphyrin versions of each variant (Figure 21b).
We next measured the T1 relaxation rates of purified MnBM3h variants in physiological buffer.
Images were taken in a single 1.63mm slice across a 384-well microtiter plate using a multi-spin multi-
echo pulse sequence in a 4.7 T MRI scanner (Figure 22). MnBM3h and FeBM3h proteins were diluted at
a range of concentrations, and T1 relaxation rates were fit from scans at a range of repetition times (TR
= 73 ms to 5000 ms, TE = 10 ms). FeBM3h concentration was determined spectrophotometrically by
CO-binding to reduced BM3h. This FeBM3h protein of known concentration was then used to as a
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Figure 21. Recombinant expression of MnBM3h proteins in E. coil by coexpression of the heme
transporter ChuA. (a) Coexpression of ChuA and BM3h in IPTG-induced whole bacterial lysates
separated by SDS-PAGE. Left: Coomassie Brilliant Blue G-250. Right: Ni-NTA dye stained gel, imaged
with UV transillumination. Upper arrow indicates likely ChuA product, and lower arrow indicates His6-
tagged BM3h. (b) Purified FeBM3h and MnBM3h variants from ChuA coexpressing cells separated by
7.5% native PAGE in 50 mM imidazole-HEPES, pH 7.6 and visualized by their native coloring under white
light. (c) UV/Vis absorbance spectra of three purified MnBM3h variants in PBS.
Relaxivity is the linear slope relating relaxation rate to contrast agent concentration. The three
MnBM3h variants showed, on average, 3.6-fold higher T1 relaxivity (mean ± S.D. = 5.1 ± 0.6 mM1 s-1)
compared to FeBM3h (1.4 mM1 s-'). MnBM3h produced from a wildtype BM3h sequence had the
highest relaxivity (5.7 mM~1 s-1), whereas mutants MnBM3h-8C8 and MnBM3h-B7 showed relaxivities of
5.0 mM~1 s~1 and 4.5 mM1 s~1, respectively (Figure 22b). For T1-weighted scans, this translates directly to
a perceptible contrast enhancement at micromolar concentrations in physiological buffer.
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Figure 22. MnBM3h proteins produced in E. coil by ChuA coexpression show increased T, relaxivity.
(a) T1-weighted MSME MRI scan taken in 1.63-mm slice across wells of a 384 well microtiter plate filled
with purified MnBM3h-B7 protein in PBS, where concentration increases linearly in the direction of the
arrow (TE = 10 ms, TR = 298 ms). (b) T1 relaxivities fit from data as in (a) taken with TE = 10 ms and TR =


























Figure 23. MnB7 binds DA with millimolar affinity and has a DA-dependent T, relaxivity effect. (a) UV
absorbance spectra of MnB7 protein in PBS mixed with fresh DA at a range of indicated concentrations
at room temperature. (b) T-weighted MSME MRI scan taken in 1.63-mm slice across wells of a 384 well
microtiter plate filled with purified MnBM3h-B7 protein dilutions alone (top row) or with 108 pM
protein protein and DA at a range of concentrations (bottom row) in PBS, where concentration of
protein (top) or DA (bottom) increases linearly in the direction of the arrow (TE = 10 ms, TR = 298 ms).
(b) Normalized T1 relaxation rates (o) and normalized absorbance difference (e) at a range of DA
concentrations. Fit equilibrium dissociation constant Kd= 5 mM by both methods.
3.3.4 MnBM3h-B7 retains a low dopamine binding affinity and an associated relaxivity effect
Having shown that manganese substitution generates BM3h proteins with improved T1
relaxivity, we explored whether MnBM3h variants could bind substrates in a manner affecting their
relaxivity. MnPPIX-substituted wildtype BM3h and DA-binding mutants B7 and 8C8 were mixed with
dopamine (DA) and were examined by UV/Vis spectrophotometry and T-weighted MRI (Figure 23).
Difference spectra were taken, and the difference between local minimum and maximum were plotted
as a function of ligand concentration [50]. Only MnBM3h-B7 showed measurable affinity for DA at Kd -
5 mM. A concomitant effect on T1 relaxivity was observable, although relaxivity was not entirely
abolished even at the highest DA concentrations.
Interestingly, titrations of micromolar concentrations of arachidonic acid (AA) against MnB7 also
exhibited a detectable absorbance and relaxivity effect (Figure 24), although the two effects had
disagreeing equilibrium dissociation constants (Kd,n = 76 uM, Kd,ab= 257 pM), suggesting that they may
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Figure 24. MnBM3h-B7 binds arachidonic acid with micromolar affinity. (a) Normalized absorbance
taken from difference spectra of MnBM3h-B7 titrated with AA at a range of concentrations. Fit Kd= 76
pM. (b) Normalized change in 1/T1 longitudinal relaxation rates of MnBM3h-B7 titrated with AA at a
range of concentrations. Fit Kd= 257 pM.
3.4 Discussion and Future Directions
While the observed 3.6-fold mean relaxivity enhancement of manganese substituted BM3h
proteins is substantial, it is approximately half of the maximal ideal relaxivity gain expected by SBM
theory. As mentioned, the expectation of an 8-fold relaxivity gain is based on a superficial analysis of
the differences in total spin of the paramagnetic ions Fe(Ill), S = /2 in the low spin configuration, and
Mn(lIl), S = 2 in the typical high spin configuration. Importantly, it has been reported that BM3h is in a
quantum mixed spin state meaning that the actual spin is between S = 1/2 and S = 5/2 [118]. Shapiro et
al. also observed that saturated binding of certain ligands, including dopamine, stabilizes a red-shifted
Soret absorbance peak in BM3h proteins, supporting the notion that BM3h is in a mixed spin state [50].
Under the somewhat shaky assumption that spin alone is responsible for the observed
differences in relaxivity, then it might be possible to estimate the basal Fe(Ill) spin based on the fold-
change in T1 relaxivity upon manganese substitution (i.e. to a stable S = 2 system). This idealized
calculation suggests that S = 0.88 for Fe(Ill)-containing BM3h proteins, which one could consider a
reasonable number given the small (~3 nm) shift observed upon DA binding [50].
Alternatively, a number of other parameters in SBM inner sphere theory may also change in
tandem when switching between the Fe(Ill) and Mn(lll) systems. For example, the bound water
residence time, TM, and the electron relaxation time, Tie, are likely to be perturbed in somewhat
unpredictable ways. Also, subtle changes in the length of the coordinated water-metal bond will
strongly affect the distance of closest approach of water protons, which has a dramatic 1r6 impact on
inner sphere relaxivity. Accordingly, it is imaginable that a number of these effects are simultaneously
at play when comparing the relaxivities of the Mn(Ill) and Fe(Ill) containing BM3h proteins. Further
investigations, by NMRD, ESR, and structural methods may help to uncover new avenues of rationally
engineerable parameter space to maximize BM3h protein relaxivity. Screening techniques, such as
directed evolution, may also be valuable in further maximizing the T1 relaxation properties of the
substituted protein.
A negative impact of manganese substitution on ligand binding affinity was expected, but the
large magnitude of the effect was somewhat surprising. EPR evidence suggests that Mn(lll) may sit
somewhat out of the porphyrin plane, perhaps substantially perturbing the cysteine ligand orientation in
a manner that occludes substrate binding [119].
That binding of dopamine at high concentrations to the variant MnBM3h-B7 does not
completely abolish relaxivity is worthy of further inquiry. There are several noncompeting explanations
that could be posited for this effect. First, DA may not bind in a manner that entirely occludes water
coordination, such that the observed effects are due to changes in the water exchange rate or outer
sphere effects on uncoordinated waters. Less optimistically, it is conceivable that millimolar DA
concentrations may have allosteric effects on conformation that could affect water exchange in a
manner that does not involve direct DA binding near the metalloporphyrin.
The advancement made here demonstrates a substantially improved static T1 contrast effect
arising from BM3h. Ultimately, we see the value of this work as a platform for developing high relaxivity
sensors for molecules of interest in fMRI, such as small molecule neurotransmitters. Advancing to this
stage will require yield optimization of the ChuA expression system used here to enable high throughput
screening approaches in small bacterial culture volumes.
3.5 Materials and Methods
3.5.1 Expression and purification of recombinant BM3h proteins
BM3h proteins were expressed recombinantly in E. coli and purified essentially as described
[50]. Briefly, terrific broth (TB) containing 100 ptg/mL ampicillin or carbenicillin was inoculated 1:100
with a fresh overnight cultures of BL21(DE3) cells (Invitrogen) carrying a pCWori vector containing the
open reading frame of wildtype cytochrome P-450 BM-3 generously provided by F Arnold at Caltech.
The gene was cloned as a heme domain truncation under the control of a T7/lacl inducible
promoter/repressor system, and both wildtype and DA-binding mutants described elsewhere [REF in
submission] were used in this study. Cultures were grown with vigorous shaking at 370C to late log
phase (OD600 = 0.8 - 1) and then induced for 18-24 hours at 300 C by addition of 0.6 mM IPTG and
supplemented with 0.6 mM 5-aminolevulinic acid (Sigma-Aldrich), a heme precursor. Cells were
harvested and lysed using Bugbuster lysis buffer containing lysozyme and benzonase (Novagen)
essentially as per the manufacturer's protocol with the addition of an EDTA-free protease inhibitor
cocktail set (EMD Biosciences) diluted 1:1000. Lysates were clarified by centrifugation and affinity
purified using Ni-NTA agarose Superflow resin (Qiagen) essentially by the manufacturer's protocol.
Eluted protein was concentrated in an Amicon Ultra centrifugal filtration device (30 kDa MWCO,
Millipore) at 40C. The filter retentate was then desalted and buffer exchanged by gel filtration on a G-25
sephadex column (GE Amersham) equilibrated with 1X PBS and then reconcentrated. Expression and
purity were analyzed by SDS-PAGE with Coomassie Brilliant Blue staining.
3.5.2 In vitro production of BM3h apoprotein, and affinity chromatographic reconstitution
with MnPPIX
BM3h apoprotein was produced using a method described elsewhere [113]. Briefly, to generate
apoprotein, purified BM3h protein at ~200 - 300 iM was added drip-wise to a vigorously stirring bath of
ice-cold acetone containing 0.2% (v/v) concentrated HCI. The white precipitate was washed in acetone
and dissolved at ~10 mg/mL in 8M urea, 100mM sodium phosphate, 150mM NaCl, pH 8.0 overnight at
40C.
Aliquots of ~10 mg/mL apoprotein were partially reconstituted by diluting 0.2X into 50mM
sodium phosphate pH 8.0, 300mM NaCl, 20mM imidazole, 0.1 mg/mL MnPPIX (from a DMF stock) to a
final urea concentration of 1.6M urea. This solution was incubated briefly at room temperature before
loading onto a Ni-NTA agarose column. The column was washed extensively with 50mM sodium
phosphate pH 8.0, 300mM NaCl, 20mM imidazole buffer and eluted with the same buffer containing
250mM imidazole. The eluate was concentrated using a 30kDa Amicon Ultra centrifugal filter (Millipore)
at 40C. Soluble retentate was then desalted using a PD-10 disposable Sephadex G-25 gel filtration
column (GE Amersham) equilibrated in PBS and then reconcentrated by centrifugal filtration. Samples
were separated by native PAGE using 4%-7.5% Tris-HCI gels in a 50mM imidazole-HEPES pH 7.5 running
buffer at 40C and proteins were visualized by their native coloring or by Coomassie Brilliant Blue staining
(SimplyBlue SafeStain, Invitrogen).
3.5.3 Concentration determination for BM3h and MnBM3h proteins
Purified FeBM3h protein concentration was quantified using a well established carbon
monoxide binding assay [50]. Briefly, a series of dilutions of protein were dissolved in of 100mM Tris-
HCI pH 8.0, and an aliquot of sodium dithionite was added and rapidly mixed. A blanking UV/Vis
spectrum was recorded for the reduced hemoprotein. Protein solutions were then bubbled briefly with
CO, and spectra were taken at regular intervals until CO saturation was apparent. Concentration was
calculated at 450 nm using a molar extinction coefficient of 91,000 M-' cm- after a baseline correction
with the absorbance at 490 nm. To quantify Mn(ll)-substituted BM3h (MnBM3h) concentrations, a
colorimetric protein assay (Pierce 660nm Protein Assay, Pierce) was calibrated using dilutions of BM3h
protein of predetermined concentration by CO-binding.
3.5.4 Circular dichroism spectrometry
Protein samples were diluted into a 0.2 micron-filtered buffer containing 10mM potassium
phosphate pH 7.4, 100mM ammonium sulfate in a quartz cuvette with 1 mm path length. All scans were
blanked using the same buffer and cuvette. Ellipticiy was measured between 300nm - 195nm with 2-
sec averaging at 250C in an Aviv Model 202 Circular Dichroism Spectrometer.
3.5.5 Recombinant production of Mn(IH)-substituted BM3h protein by apoprotein refolding
in bacterial lysates
E. coli strain BL21(DE3) transformants carrying pCWori-BM3h plasmid were grown to mid-log
phase at 370C in M9 minimal media supplemented with 2% glucose, 34 pg/mL thiamine, 0.2% casamino
acids, 2mM MgSO4 and 0.1mM CaCl 2. Cells were then induced overnight at 300C by addition of 1mM
IPTG. Lysates were generated using Bugbuster, benzonase, lysozyme, and protease inhibitors and
incubated overnight at 40 C with 50ptg/mL MnPPIX from a 5 mg/mL stock in 1:1 DMSO/acetone with 1%
(v/v) concentrated HCL. Soluble MnBM3h protein was purified by Ni-NTA agarose affinity
chromatography and gel filtration in the same manner as native BM3h proteins. Purity and
conformation were assessed by UV/Vis spectrophotometry, SDS-PAGE, native PAGE separation with
Coomassie Brilliant Blue staining, and circular dichroism.
3.5.6 Cloning and expression of the bacterial heme transporter ChuA
The heme transporter ChuA was cloned from 0157:H7 E. coli genomic DNA (ATCC) using
standard directional cloning methods. Briefly, full-length ORF of ChuA was amplified by PCR using
primers with 5' extensions containing upstream Ncol and downstream Xhol restriction sites. The
amplification product was confirmed by gel electrophoresis, purified, digested with Ncol/Xhol, and
ligated into the corresponding sites in a digested pET28a vector (Novagen). Plasmid purified from
isolated clones was digested and analyzed by gel electrophoresis and sequenced to confirm the desired
construct. For protein expression, single clones were selected on 50 ig/mL kanamycin from chemically
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competent BL21(DE3) Star E. coli (Invitrogen) transformed with pET28-ChuA. Cultures grown in
supplemented M9 minimal media were induced in early-log phase under kanamycin selection, and the
IPTG-dependent expression of the desired 72 kDa gene product was confirmed by Coomassie Brilliant
Blue staining of SDS-PAGE separated whole cell lysates.
3.5.7 Recombinant production of Mn(HI)-substituted BM3h protein by ChuA heme
transporter coexpression
Separate plasmids containing ChuA and BM3h constructs were cotransformed into BL21(DE3)
Star E. coli, and isolated clones were selected on kanamycin and ampicillin. Vigorously shaking cultures
inoculated 1:100 from fresh overnight cultures were grown at 370C to OD600 = 0.4 in M9 minimal media
supplemented with 2% glucose, 34 ptg/mL thiamine, 0.2% casamino acids, 2mM MgSO 4 and 0.1mM
CaCl 2. Protein expression was induced overnight at 290C by addition of 1mM IPTG and the growth
medium was simultaneously supplemented with 30 pig/mL MnPPIX from a 3 mg/mL
DMSO/acetone/1%(v/v) concentrated HCI stock. Cells were harvested, washed in PBS, and lysed in
Bugbuster lysis buffer containing lysozyme, benzonase, and protease inhibitors. Lysates were clarified
by centrifugation and incubated overnight at 40C with Ni-NTA Superflow agarose (Qiagen) and purified
under native conditions essentially as described for native BM3h. Purity and conformation were
assessed by UV/Vis spectrophotometry, SDS-PAGE, native PAGE separation with Coomassie Brilliant Blue
staining, and circular dichroism.
3.5.8 MRI relaxometry
Protein samples were diluted in 0.2 micron filtered phosphate buffered saline (PBS) pH 7.4 into
384-well microtiter plate wells (BD Falcon) in a linear range of concentrations, and peripheral plate wells
were filled with buffer alone. The plate was imaged at room temperature in a 4.7 T Bruker Avance
animal scanner with a 40cm-bore. Images were taken in a 1.63-mm slice across the plate using a multi-
spin multi-echo (MSME) pulse sequence with the following parameters. Time to echo (TE) was 10 ms for
all scans. Repetition time (TR) ranged from 73 ms to 5000 ms, and averaging was correspondingly
adjusted from 64 to 4 scans per TR. T1 relaxation rates were fit from reconstructed image data using
custom routines developed in Matlab (Mathworks).
3.5.9 Spectrophotometric and relaxometric ligand titration with MnBM3h proteins
Ligand binding titrations were performed essentially as described [50]. Briefly, MnBM3h
proteins at ~30IiM were mixed in PBS with freshly prepared DA or AA at a range of concentrations in a
microtiter plate. Absorbance spectra were taken from 250 nm - 600 nm, and difference spectra were
generated by baseline subtraction of protein without ligand. Titrations were plotted as the normalized
difference between the local maximum and minimum in the difference spectrum. The data was plotted
versus ligand concentration and fit to a sigmoid to determine Kd. Similarly prepared plates were imaged
using a MSME pulse sequence, as described above. Titration curves were fitted to normalized T1
relaxation times as a function of ligand concentration.
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4 Conclusions
Advancing neuroscience productively into the "systems" realm relies critically on technology
that can assay dynamic molecular phenotype noninvasively as a function of stimuli and genetic
manipulations. Noninvasive molecular fMRI would have unique value for interrogating function in the
brain, but several obstacles must be overcome to bring such a technique to fruition. In this chapter, I
will briefly discuss some of these challenges with reference to the two concrete advances described in
this thesis.
First, in designing and building an aggregation device that is calcium-dependent, we
demonstrated a new design for derivative devices, employing an engineered multivalent protein
crosslinker with molecular specificity to inducibly cluster a contrast agent. Several groups, including our
own, have previously conceived of aggregation-based sensors as requiring two chemically-distinct
populations of contrast agents that aggregate or disaggregate depending on ligand concentration or
enzyme activity [43,45,51]. It is likely that the primary motive for these initial designs was to minimize
the interparticle spacing within the aggregate and thereby maximize the corresponding relaxivity gain.
However, Monte Carlo simulations of superparamagnetic nanoparticle aggregation recently undertaken
in our group have revealed that the critical length scales for interparticle distance are on the order of a
few particle diameters [44]. Bennett et al. have also computationally examined the importance of
spacing in the context of ferritin aggregates and found the optimal length scale to be far longer, perhaps
an order of magnitude larger than the core particle diameter [75]. These computational studies suggest
that interparticle spacing may be a more flexible design parameter for aggregation-contrast devices than
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previously thought. To our knowledge and as of this writing, computational studies of the effect of
interparticle spacing on aggregation-based T2 relaxation enhancement have not been fully validated by
empirical results. This is undoubtedly a potential avenue of future work, as improvements in the
theoretical underpinnings of aggregation-based contrast mechanisms can be employed to design
optimal sensors for molecular fMRI.
Any engineered contrast agent for molecular imaging must be deliverable in vivo. Especially for
those sensors whose intended function is intracellular, our long term approach will be to exploit well
established genetic strategies for tissue specific expression in vivo [35]. However, the in vivo context
brings with it enormous peripheral complexity and day-to-day technical uncertainty, which may yield
limited instructive value from the immediate application of these nascent technologies in live animals.
Much can be learned about optimizing design and experimental strategies in cell culture, as has been
the case in other imaging modalities.
Of specific concern are endogenous factors that could readily compete for interactions with
sensor components, especially those that are based on modified normal cellular proteins, such as those
employed in the calcium sensor presented here. It is conceivable that these off-target effects will mean
that higher (and therefore less efficient) concentrations of sensing components will be necessary for
operation above these "nonspecific" interactions. This criterion must then be balanced against the
impact of high sensor concentrations on normal cell processes. Nagai et al. have demonstrated that
genetically-encoded fluorescence sensors can provide meaningful insights into calcium dynamics despite
the potential for off-target interactions [47], but efforts to eschew these interactions have also been
undertaken [87]. These efforts, as well as our own [88], should undoubtedly be exploited in future
refinements of our MRI calcium sensor. For example, a skeptical analysis of in vitro pilot tests (described
in Section 2.4.5) of calcium-dependent sensor aggregation in dilute cell lysate lends credence to this
concern, since less overall aggregation was found to occur for any given incubation ratio than in buffer
alone (Figure 13). Future work to produce orthogonal binding partners selected away from significant
off-target interactions would yield a device that interacts minimally with confounding cellular
components.
Aggregation based T2 sensors have the potential to be sensitive to vanishingly small
concentration dynamics, where their primary limitation will be in the kinetics of aggregation and
disaggregation. On the other hand, T1 sensors, as we have thus far conceived of them, must tackle
certain pragmatic problems related to their low basal relaxivities and the low endogenous
concentrations of interesting targets. Without significant technological advancement, it will be
challenging to detect nanomolar dynamics using contrast sensor concentrations in the tens of
micromolar above instrument noise.
In this work, we have begun to address that concern by producing an engineered metalloprotein
consisting of manganese porphyrin substituted cytochrome P-450 BM3h. The signal gain associated
with this advancement was approximately 3.6-fold at 4.7 T, which translates directly into an equivalent
MRI signal gain for any given concentration employed in vivo. Accordingly, contrast could be achieved in
the low micromolar range using this new agent, and a 1% change in sensor relaxivity could then be
detectable for ligands in the hundreds-of-nanomolar range on our instrument. This is a significant
advancement and brings the dynamics of numerous neurological targets within sensible reach, including
an array of synaptic neurotransmitters and intracellular second messengers.
As a platform for T1 sensors for molecular fMRI, the future challenge for MnBM3h will be to
develop binding affinity for interesting molecular targets. In this regard, fruitful efforts by Frances
Arnold in collaboration with our group to use directed evolution as a means to select for desirable traits
in cytochrome P450 enzymes have already yielded BM3h variants with high affinity for dopamine [50].
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Work is already underway to adapt the ChuA-mediated porphyrin substitution expression system
described here and pioneered by others [114,115,117] to a high throughput screening format. Such
developments will permit further screening-based optimization of important parameters for future
applications, including binding affinity, kinetics and thermostability.
Technological advancement of practical molecular fMRI sensors is a unique biological
engineering challenge, one that draws interdisciplinary knowledge from a range of fields and
techniques. As observed in other applications, protein engineering approaches that take advantage of
both rational design and evolutionary refinement exhibit the most demonstrative success. Since the
design efforts described here have been rational in nature, further advancement should undoubtedly
exploit the tremendous possibilities of directed evolution. The observable results of natural evolution-
the vast molecular complexity of nature-should give confidence that simple genetically-encodable
devices are within the biological engineer's grasp.
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